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Abstract 
Surgical care is a fundamental component of an effective healthcare system, yet most 
people living in low and middle-income countries have no access to it. Critical to addressing 
this is the ability to equip low-resource healthcare contexts with appropriate surgical 
technologies. An estimated 40% of healthcare equipment is unused in these contexts, and 
there is increasing recognition that new technologies must be designed specifically for them, 
to provide Affordable, Available, Accessible, Appropriate and Quality solutions.  
For this, researchers suggest conventional approaches to medical device design are not 
appropriate, but recommended alternative approaches are in early development stages, 
and since their use is rarely reported in the literature, little evidence exists with which to 
improve them. This thesis addresses this paucity of evidence, and describes the integration, 
implementation, and evaluation of recommended approaches to designing technologies for 
low-resource healthcare contexts.  
A design roadmap, and the principles of frugal innovation and participatory design are 
applied to design a device for gasless laparoscopy in rural hospitals in Northeast India. The 
evaluation of these approaches considers their influence on the development of the design 
through a review of the design history of the device and uses an exploratory qualitative 
study to understand whether the participatory approach was beneficial to the clinical 
stakeholders, who were participants. 
The design roadmap provided appropriate structure and advice for the design process but 
requires further development. A thorough understanding of the use context, local 
stakeholder participation and ability to maintain quality are important for innovating 
frugally, but specific methods to guide frugal innovation are required. Clinical stakeholders 
benefited from participating throughout the design process and supported the process by 
revealing potential barriers to collaboration as well as potential solutions to them. The 
results highlight the value and potential for using these approaches to increase global access 
to surgical care. 
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Chapter 1 
Introduction 
This chapter introduces the context within which the research project and objectives evolved. 
The state of global access to surgical care and the approach taken by a Global Health 
Research Group to improve this is summarised. Through involvement in this work, it became 
clear to the author that the majority of surgical technologies do not meet the needs of 
surgical providers in low-resource settings. Addressing these needs requires a different 
design approach, which is not well understood. This becomes the justification for the aims 
and objectives of this research and the methods selected to achieve them.  
1.1 Context 
The work described in this thesis was conducted as part of wider research into improving 
surgical care in low-resource healthcare contexts (LRHCs), coordinated by the Global Health 
Research Group in Surgical Technologies (GHRG-ST), which is funded by the United 
Kingdom’s (UK) National Institute for Health Research (NIHR) as part of an initiative to 
address ‘Global Health’ concerns across a range of clinical domains. According to the UK 
government, ‘Global Health’ concerns affect people worldwide and require international 
collaboration to address 1. 
1.1.1 Inequality and Privation in Global Access to Surgical Care 
As a part of the Sustainable Development Goals (SDGs) 2, Member States of the United 
Nations (UN) pledged to achieve Universal Health Coverage (UHC) by 2030. Providing 
essential health services reduces morbidity and mortality for their populations and gives 
them better chances of avoiding poverty and enjoying long-term economic development 2–
4. Surgical care is one of these essential health services 3,5,6. To be effective, it must be safe, 
quality, timely, accessible and affordable 7.  
An estimated 5 billion people lack access to surgical care. While these people exist 
worldwide, they are disproportionately concentrated in Low- and Middle- Income Countries 
(LMICs), where nine in ten people cannot access surgery 3. Health burdens can be measured 
in Disability-Adjusted Life Years (DALYs), which sum the number of years of life expected to 
be lost and the number of years of life expected to be affected by disability for a cause 8. 
Access to surgery could avert 77.2 million DALYs in LMICs every year 9. 
In sub-Saharan Africa, under the right conditions, this could cost just $33 per DALY prevented 
10. In fact, one study found that almost all surgical interventions they assessed were very 
cost-effective in LMICs 11. Despite this, the costs incurred accessing surgery in LMICs can 
- 2 - 
cause entire households to fall below the poverty line 3,12. To prevent this and achieve UHC 
2, the international community must prioritize and invest in surgery 3. Financial flows into 
surgery must be tracked and surgical data collected to better inform policy. And finally, we 
must utilise innovation and technology to reduce costs and optimise resource allocation in 
the delivery of surgical and anaesthesia care in LRHCs 3,13. 
1.1.2 Using Innovation to Improve Access to Surgery 
The GHRG-ST has supported increased use of one such innovation, gasless laparoscopy 14, as 
a means of superseding laparotomy and improving surgical care in LRHCs. Laparotomy is one 
of the Bellwether procedures, which all first-level hospitals should have capacity to perform 
15. Where possible, it is replaced by laparoscopy, because of benefits such as shortened 
hospital stays, reduced pain, smaller wounds, and overall cost savings 16. For low-earning 
populations, especially those with no leave or sick pay, days spent accessing surgical care 
come at the cost of losing wages, so these benefits are more pronounced. However 
laparoscopy is not currently feasible in many LRHCs. Conventionally, it is performed by 
‘insufflating’ (inflating) the abdominal cavity using pressure-controlled carbon dioxide gas 
(CO2) (termed a pneumoperitoneum) which requires use of a general anaesthetic, 
monitored by an anaesthetist. This, alongside other specialist equipment and consumables 
required, places a high resource requirement on the technique which is challenging to 
provide in LRHCs. Hence, adoption of laparoscopy in LMICs has been slow 17. 
Gasless laparoscopy is an alternative method, using a device that manually lifts the 
abdominal wall 18. It can be performed under spinal (rather than general) anaesthesia and 
without pressurised CO2 gas, thus removing the need for associated equipment: a significant 
reduction in resource required. It could also reduce the risk of airborne viral transmission 
during laparoscopy 19–21. Scoping work conducted by GHRG-ST identified opportunities and 
barriers to uptake of this technique 22, which have formed cornerstones of the 
multidisciplinary research group’s work: 
 Training and proctorship 23,24 
 Registry and long-term advocacy 25 
 Equipment 26 
The last is the focus of this work. To increase the adoption of gasless laparoscopy, it must 
provide a comparable alternative to conventional laparoscopy. Studies currently report 
challenges such as longer operative times and a suboptimal view of the operative scene 27,28, 
central to which are the abdominal wall lift (AWL) devices, shown in Figure 1, which lack the 
- 3 - 
development and innovation seen in instrumentation used for main-stream surgery 29. 
Accordingly, the GHRG-ST has been developing an improved AWL device, the Retractor for 
Abdominal Insufflation-Less Surgery (RAIS). 
 
Figure 1: Principles of gasless laparoscopy and an existing abdominal wall lift device, 
currently in use in North-east India, from Marriott Webb et al. 26. 
1.1.3 Designing a Technology for Global Surgery  
Designing new health technologies is generally a difficult, but well-researched process. 
Established frameworks can be used to guide development, from identifying innovation 
opportunities through to product decommissioning 30. However, designing surgical systems 
for LRHCs brings additional considerations and challenges. Limited existing literature on the 
topic, reviewed in Chapter 2, suggests that conventional processes are inappropriate. 
Alternative approaches have been proposed but appear inchoate, leading to varied 
interpretation and implementation by innovators and a lack of evidence with which to assess 
or improve them.  
Therefore this research explores approaches to designing surgical technologies for LRHCs. 
Designing the RAIS system is used as a case-study to inform this research, providing evidence 
and tangible examples of implementing the approaches. One approach, which recommends 
- 4 - 
involving users in design, is assessed through two lenses: the impact of users on the RAIS 
design, and the impact of being involved on the users themselves, which is a novel study in 
this field. 
1.2 Thesis Aims 
The outcomes of this thesis are targeted at developing advice for innovators in designing 
disruptive surgical technologies to improve global access to quality surgery. 
Objective 1: Identify existing approaches to designing health technologies for LRHCs 
and investigate how these have been implemented. 
Objective 2: Apply selected approaches to the design of a novel surgical device for 
gasless laparoscopic surgery. 
Objective 3: Document the design process, gathering evidence and tangible 
examples of how these approaches are implemented. 
Objective 4: Critically assess the impact of the approaches on the design 
development. 
Objective 5: Investigate whether the selected design approaches benefitted the 
clinical stakeholders involved in the process. 
Objective 6: Develop evidenced recommendations for further development of these 
design approaches. 
1.3 Thesis Overview 
The thesis is presented in 6 chapters addressing the objectives in 1.2. 
Chapter 2: Literature Review 
To understand the need for a different approach to designing health technologies for LRHCs, 
the nuances of the design context are reviewed. Then Objective 1 is addressed by reviewing 
design approaches developed specifically for this context. The results of the review inform 
Chapter 3. 
Chapter 3: Design Approach 
A description of and rationale for the design approach selected to develop the RAIS device 
is provided, which includes aspects from the ‘Design for Safe Surgery Roadmap’ 31, frugal 
innovation and participatory design. 
- 5 - 
Chapter 4: Evaluation of the RAIS Design Development  
The implementation of these design approaches is described, addressing Objective 3, and 
the challenges, benefits and opportunities experienced are considered. The impact of the 
approaches on the RAIS design is evaluated by examining the design development and the 
findings of clinical and mechanical evaluations of prototypes, addressing Objective 4. 
Chapter 5: Evaluation of User Gains from the Design Approach 
An exploratory qualitative study is used to investigate clinical stakeholders’ perspectives 
what they gained from being involved in designing the RAIS device (Objective 5), and what 
facilitated and impeded these gains. The chapter concludes by reflecting on how the results 
might be used to enhance relevant outcomes of using a participatory design approach in this 
context, and hence relates the chapter content to Objective 6. 
Chapter 6: Discussion, Recommendations and Conclusions 
In the final chapter the learning outcomes of the project are summarised in six themes 
discussing important aspects of approaching designing a device for global surgery. The 
chapter concludes with recommendations for further development of the design 
approaches investigated in this thesis, to increase their usefulness for designers and create 
more impact on improving global access to surgery.  
- 6 - 
Chapter 2 
Literature Review 
The topic of surgical technology design for LRHCs is introduced with a review of current 
theories and knowledge. The first section investigates the nuances of LRHCs and why most 
technologies do not meet their needs. The second reviews benefits of using established 
design processes to develop health technologies and why they need adaptation for designing 
solutions which do meet LRHC’s needs. Accordingly, recommended approaches to designing 
technologies for LRHCs are discussed, and their use by innovators in this context reviewed. It 
is concluded that to support surgical technology innovation for LRHCs these approaches need 
further development, using evidence generated from implementing and evaluating them. 
2.1 The Need for Innovation in Surgical Technologies  
2.1.1 What is a Surgical Technology? 
For the purposes of this thesis, a surgical technology or device refers to any technology used 
during surgery which is intended for use on humans for a prescribed list of purposes, and 
does not achieve this purpose solely through pharmacological, immunological or metabolic 
means, separating them from, for example, vaccines or drugs 32. 
For regulatory purposes, a surgical technology can fall into any class of medical device 33. 
Due to a paucity of literature specifically addressing design of specifically surgical 
technologies, this review considers relevant research from the wider conversation around 
designing health technologies. Conversely, some findings of this research are likely to be 
relevant to other health technologies. 
2.1.2 Issues with Repurposing Existing Technologies 
More than prohibitively high upfront costs limits the uptake of surgical technologies in 
LRHCs. Even ‘free’ or donated surgical equipment is not always cost-effective 34–36. About 
40% of medical equipment donated to LMICs is not in use 36. When donors fail to consider 
the context technologies will be used in or consult clinical engineering and maintenance 
personnel, donations arrive without spare parts, manuals or training and soon break down 
34–37. Repair can be prohibitively expensive because the necessary expertise resides on a 
different continent 12,36,38. Equipment disposal can also be exorbitant 36,39. 
So while cost is the most frequently considered factor in procurement planning, what most 
affects successful uptake of technologies is their alignment to the deployment setting 37. 
Healthcare providers in LRHCs need technologies with technical specifications appropriate 
for their context of use that they can both afford and sustain with their resources. It must 
- 7 - 
designed for the context they work in 35,37,40.  However LMICs only account for a small 
proportion of global health research and development spending, and as almost four fifths of 
all medical device sales revenue is generated in the USA and Europe, it is no surprise that 
the majority of medical equipment is designed in and for western markets 38. This equipment 
is neither appropriate nor always safe for LRHCs, whose needs are different to those of the 
current majority market 34,41. For example, a mains-supplied surgical lighthead is sufficient 
in HICs, but some LRHCs experience frequent power outages, which could leave a surgeon 
operating blind 34,36. A light with a battery backup is better, but generally such needs are not 
widely understood. 
2.1.3 The Contexts Surgical Innovations Must Address 
To understand nuances of LRHCs and their effects on technology uptake, we can look to 
Health Technology Assessment (HTA). HTA is a growing field aiming to understand all the 
effects, intentional or not, of implementing health technologies 42. Considering the factors 
summarised in Figure 2, it provides a holistic perspective into why existing technologies can 
be unsuitable in LRHCs. 
 
Figure 2: Contextual differences to be considered when implementing a health intervention. 
Content source 43 
A crucial consideration is whether the healthcare infrastructure can support a technology 
37,43. With relatively reliable supplies of highly trained healthcare workers, consumables, 
utilities and clinical engineers, High-Resource Healthcare Contexts (HRHCs) can utilise a wide 
range of technologies 44. These technologies must conform to rigorous standards, providing 
assurance they can be safely used and interact with other devices in that context 45. If they 
don’t, procurement and legal teams can leverage the legal system to ensure the hospital or 
patient is compensated 45. In contrast, infrastructure supporting LRHCs can vary radically 46,47 
- 8 - 
and some operate with very little access it 12,22,41,45. In these settings, technologies designed 
assuming the aforementioned infrastructure is in place can be difficult to implement 37,41. 
For example contracts with suppliers, manufacturers and distributors may work differently 
48. Individual settings may generate their own solutions to infrastructural challenges, which 
should be taken into account: for example, in one hospital devices were cleaned and stored 
in Operating Theatre (OT) corridors by cleaning staff due to lack of a sterilisation department 
39. Finally, in some LRHCs resources are shared, such as specialist surgeons and equipment 
12. In such cases, portable equipment could be easier to implement: not usually a 
consideration in HRHCs 37.   
The context also influences the cost-effectiveness of health technologies 3. Both HRHCs and 
LRHCs overspend on technologies that barely improve health outcomes 38. But for LRHCs 
with limited health budgets the opportunity cost is greater. Non-upfront costs of 
technologies can also constitute 80% of the total cost, which is often an unbudgeted 
expenditure for LRHCs 38. Therefore, to be cost effective in LRHCs, technologies must address 
pressing healthcare burdens 49 and consider costs of use, training, repair, maintenance and 
disposal in that setting 3,36,39. Finally, financers of the healthcare setting varies between 
governments, insurance schemes, private ownership, NGOs or even communities, and this 
affects technologies prioritisation. Some may mandate selecting the cheapest technologies, 
regardless of cost-effectiveness, which can complicate implementing appropriate 
technologies 3,39,50.  
Implementing health technologies requires consideration of cultural values and mechanisms 
too. In some countries 80% of the population use traditional rather than modern medicine 
practitioners, such as herbal healers 12,51. Acceptability of modern health technologies can 
vary 44,52 and in some settings household or community leaders make decisions about an 
individual’s treatment, not the individual 12,53.  
Finally, the physical environment of the context must be studied. Some technologies are 
sensitive to changes in altitude, humidity, temperature and air quality and can malfunction 
in extreme environments 37,41,44. The health needs of populations also change with the 
physical environment 54.  
2.1.4 The Need for Innovative, Global Surgical Technologies 
Hence, there is demand for technologies designed to be affordable, available, appropriate, 
accessible, acceptable and quality in LRHCs 55. Surgical technologies that achieve these 
criteria have become attractive products in HIC markets too due to their low cost, high 
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quality and robustness 56. Contradicting historical flows of medical innovation from HICs to 
LMICs, this is sometimes known as reverse innovation 22,57,58. Hence, technologies designed 
for LRHCs can improve surgical care globally. The World Health Organization (WHO) 
recognised this with annual calls for innovative health technologies designed for LRHCs 
between 2010 and 2016 29. Yet despite their potential, such innovations have had low 
success rates. The most recent call identified only 39 in prototype stages and 29 
commercially available technologies, reflecting a 60.7% selection rate of technologies 
submitted with sufficient details and a 12% acceptance rate overall 29. A review of health 
technologies designed for LRHCs in 2013 also found few were implemented at scale, and 
overall failed to address the largest health burdens in LMICs 49. This suggests even the few 
innovators targeting LRHCs find designing appropriate technologies challenging.  
One possible explanation is that despite progress in HTA, comprehensive data on aspects 
discussed in 2.1.3 is rarely available for LRHCs 41. This lack of information is a barrier to 
industry investment in global health technologies 43 because designers must often make 
predictions using data from small samples of respondents 36,37,39. This, among other aspects, 
introduces risk into health technology development that the industry does not have 
established strategies to mitigate. To improve the efficacy of research and development in 
this sector and support organisations to innovate and commercialise surgical technologies 
for LRHCs at scale, it has been suggested that specific design processes to develop LRHC-
appropriate technologies may be required 49.  
2.2 Conventional Surgical Technology Development 
This section investigates conventional approaches to designing health technologies to 
understand whether they are appropriate for innovating for LRHCs.  
2.2.1 Nuances of the Industry 
Even for HRHCs, developing surgical technologies is a high-risk process 38. It is rigorously 
controlled by standards and regulatory authorities 51. Regulatory requirements are 
continuously evolving, requiring businesses to be flexible, innovative and to invest large 
sums in new technology development 30,48. It often relies on public sector input: for research, 
infrastructure, funding and even to influence the market 51. Furthermore, user perspectives 
and expectations vary significantly and often contradict those of purchasing stakeholders 30. 
Ethics are fundamental to the entire sector and must be considered throughout product 
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development processes. These challenges make project failures common and expensive, 
leading to price inflation of successful products 51. 
2.2.2 Conventional Medical Device Development Processes 
Design processes are used to navigate this complexity 59. They often consist of a 
chronological framework of and advice for completing design activities such as Quality 
Function Deployment, Functional Analysis, Pugh Matrices, Design for X or Failure Mode and 
Effects Analysis (FMEA). The Linear Stage-Gate process 60 and Medical Device Design for Six 
Sigma 61 are popular examples 59. The way in which they collect, organise and explain 
knowledge of industry experts, generated through years of successes and failures, is 
invaluable 60. Their use offers organisations benefits such as developing higher-impact 
products and reducing risk 62, but to be effective they must continuously evolve to keep up 
with healthcare contexts and be tailored to an organisation’s resources and products 59,62,63. 
2.2.3 Suitability for Use in Designing Global Surgical Technologies  
Of course, there is useful content within these processes for developing technologies for 
LRHCs. However, they are based on the experience of experts that have primarily or only 
designed technologies for HRHCs and inherently target them. The stage-gate process is a 
good example 60. Similarly to others 64, the overall structure of the process is tailored to 
comply with standards set by the United States Food and Drug Administration (US FDA) or 
the European CE mark, which may be inadequate to regulate health technologies in LMICs, 
because they do not consider the nuances of LRHCs 58,65. The design activities created with 
HRHCs in mind do not consider issues performing the same in LRHCs: for example, it suggests 
assessing the financial impact of delaying product releases, which could come at great 
human cost in LRHCs 60. Simply put, there are new priorities, risks, challenges and 
opportunities in innovating technologies for LRHCs, making existing processes less effective 
since they are no longer carefully tailored to the design context 62,63. To develop 
technologies for LRHCs, new approaches are required 22,40,65. 
2.3 Design Processes for Global Health Technologies 
To address this, authors have undertaken developing new high-level design processes 
specifically for LRHCs. Reviewing the literature revealed four such processes, which, similarly 
to conventional medical device design processes, advise on overall structuring of the design 
development and what activities should be performed at each stage 31,58,66,67. 
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2.3.1 The Stanford Biodesign Process 
The Stanford Biodesign process is the most established of these 67. While the first edition 
focuses primarily on innovation in HRHCs 68, the second edition recognizes different global 
contexts necessitate different design considerations.  
The overall structure (Figure 3) of the process remains very similar to the edition developed 
for the US market. Instead of adapting the process itself, the authors add supplementary 
advice for different global healthcare markets, including a background, a discussion of 
context-specific challenges and an array of tactics for innovators to utilise. For example, in 
India, one should ‘search for needs in country’, ‘go deep on stakeholder analysis’ and ‘keep 
innovating beyond the technology’ 67.  
 
Figure 3: Stanford Biodesign Process. Adapted from 67 
 
Again, this raises questions as to whether conventional medical device design processes may 
be adequate for LRHCs. However what separates the Biodesign process from for example, 
the Stage-Gate Model 60 is its focus, from project initiation, on addressing clinical needs and 
creating value for stakeholders (see 2.4.1 for more on value innovation). The purchasing 
power of LRHCs is low and concentrating spending where it can create the greatest health 
benefit is important. Therefore, identifying a pressing clinical need to address is the first step 
towards designing global health technologies. On this, many processes agree 31,58,66,67,69,70. 
2.3.2 The Globally Responsive Device Realization Process 
While less detailed, and not fully expanded upon, the  ‘Globally Responsive Device 
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advice: one should recognize the importance of local clinical stakeholder experience in both 
need identification and implementation stages. The involvement of local stakeholders is a 
second matter agreed upon by all processes reviewed, and is discussed further in 2.4.2.  
2.3.3 The Design Thinking Process 
In fact, two innovators 66,69 went so far as to utilise a ‘Design Thinking’, or human-centered 
process for this design context. Not specifically intended for the design of health 
technologies, this process sets out broad steps (empathize, define, ideate, prototype, test, 
refine) intended to ensure continuous integration of stakeholder feedback and priorities into 
a design process. Each identified that this process alone was not sufficient to guide their 
development process and ensure the success of their product 66,69. However, both 
successfully adapted the ‘Design Thinking’ structure, notably implementing their products 
at scale, and supplemented it with their own insights to guide future innovators. 
2.3.4 The Roadmap for Design of Surgical Equipment for Safe Surgery Worldwide 
In contrast to the ‘Design Thinking’ approach, which is applicable to many design contexts, 
Oosting et al. (2018) developed a specific process for designing surgical devices for global 
contexts: the four-phase ‘Roadmap for Design of Surgical Equipment for Safe Surgery 
Worldwide’ (Design for Safe Surgery Roadmap) (Oosting et al., 2018). The roadmap (Oosting 
et al., 2018) is more limited in scope than the Biodesign process, but more detailed and 
specific to a healthcare context than the ‘Design Thinking’ structure, while also placing 
emphasis on understanding and addressing nuances particular to LRHCs. Phase 0 of the 
roadmap (Oosting et al., 2018) focuses on identifying an unmet health need and Phase 1 on 
understanding the local context. Phase 2 concerns determining the design requirements and 
a strategy for implementing the device. Finally, Phase 3 is to ‘Act’, engaging in co-creation 
with LMIC stakeholders to produce a design and prototypes.   
Collectively there is little evidence of these design processes being used in the literature, 
and similarly they are infrequently cited by studies which encourage innovation for 
addressing the need for appropriate technologies in LRHCs. In fact, in providing advice for 
innovators in this design context, more studies describe two core principles for design, which 
are discussed in the following section. 
2.4 Core Principles for Designing Global Health Technologies 
Several reviews identified two core tenets to designing and implementing global health 
technologies, which resonate with aspects of the design processes reviewed in 2.3: 
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participatory design (PD) and frugal innovation (FI) 3,22,37,38,40,44,49,55,71. Instead of providing 
step-by-step design frameworks, these concepts describe design process aims, and 
principles which the designer should use to achieve them. 
2.4.1 Frugal Innovation 
2.4.1.1 Definition and general use 
FI can refer to the process of designing frugal products or to the product itself. The FI 
process, also known as ‘Jugaad’, ‘good-enough’ or ‘value’ 57,72,73, is often simply described as 
providing more value to users using less resources 22. FIs have been disruptive across 
different industries, from Tata’s ‘Tata Nano’ 74, the world’s cheapest car, to the ‘Foldscope’ 
75, an origami microscope costing less than a dollar. According to Weyrauch and Herstatt 76, 
who have, in the author’s opinion, considered definition of FI most thoroughly 77–79, FIs have 
three attributes (Figure 4) in common: “substantial cost reduction, concentration on core 
functionalities, and optimised performance level” 76.  
 
Figure 4: Principles of Frugal Innovation. Content source 76 
 
Hence FI encompasses more than cost-cutting or the problematic term ‘simplification’: a 
product can achieve the criteria with a complex or creative solution, but it must be low-cost 
and meticulously optimised for its purpose 80,81. Avoiding over-design and inclusion of 
unnecessary functions facilitates increased value for stakeholders over conventional 
solutions 82.  
2.4.1.2 Use in designing technologies for LRHCs 
Several aspects of FI make it favourable for designing technologies for LRHCs. With large 
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and focus on affordability for the Base of the Pyramid is key 83,84, crucially without 
compromise on quality and robustness, which in healthcare is paramount. Examples of 
frugal surgical innovations include adapting cheap mosquito netting to replace surgical 
meshes in hernia repairs 82 and use of a flutter valve to drain fluids and air out of the thorax 
57. By providing comparable performance to existing technologies at a fraction of the cost, 
these innovations are disrupting the norms of innovation in the health technology sector 
and have the potential to improve surgical care in both LMICs and HICs 22. Through calculated 
value optimisation FIs also frequently result in lower training and maintenance needs along 
with high robustness: desirable characteristics of products designed for LRHCs 22,40(p),44,57,73.  
While the principles and theoretical frameworks describing FI are well-defined, methods for 
implementing it are not 76,77,79. It is described as a complex process which has implications 
across all innovation functions, but there are few specific methods or design tools innovators 
can use to help their surgical innovations meet the ‘frugal criteria’ and they are not typically 
explored in-depth 77,79,85. Instead, studies present varying and sometimes conflicting 
common features of FIs for designers to consider: for example ‘lightweight’ or ‘adaptable’ 
or ‘use of local materials / manufacturing’ 79,86,87. These have limited practical use for 
designers: while they can set the objectives for innovation, they lack the detail to help 
designers prioritise these objectives according to the setting and achieve the delicate 
balance of optimising performance 76,85.  
However, studies agree on one FI method: engaging and co-creating with ‘prosumers’, or 
stakeholders, in design 22,77–79. Bringing together expertise from diverse settings and 
professions can enhance a team’s ability to innovate frugally, and be fundamental to the 
success of those innovations 88. Stakeholders can influence consumer behaviour whilst 
adding to the design team’s competencies, facilitating new thinking 79. In fact, many frugal 
surgical innovations originate in LMICs, where innovators have first-hand knowledge of 
LRHCs or access to stakeholders who do 57,73. Often, while a major barrier to health 
technology designers in developing optimised frugal, global devices is a paucity of 
information on the context of use 89, a barrier to frugal innovators in LRHCs developing 
technologies is lack of experience in for example, navigating regulatory requirements and 
certifying products 73, or a lack of resources to support a full research and development 
process 44. It is unsurprising then, that PD is mentioned frequently alongside FI 44,58 and it is 
predicted that multinational corporations with operations in LMICs will accelerate frugal 
technology development 44.  
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2.4.2 Participatory Design 
2.4.2.1 Definition and general use 
Central to PD is the argument that individuals should be involved in the design of systems 
that they interact or produce work with 90. It has different forms, including, but not limited 
to, ‘co-design’, ‘co-creation’, ‘cooperative design’ and ‘design thinking’ 91, but all are linked 
by a common idea. The idea is that some additional benefit, whether an improved system 
performance, learning and development of participating stakeholders, or something 
different, can be achieved through engaging stakeholders affected by a system’s design in 
the process of designing it 92. Although frequently interpreted to mean the same, PD is 
distinct from user-centred design, which is considered necessary in all health technology 
development for safety reasons and can be a regulatory requirement for a medical device 
design process 93,94. Rather than collecting knowledge from stakeholders to feed into design 
activities, PD projects ensure stakeholders participate in design activities themselves 69,95. 
PD has been frequently recommended as a principle for designing appropriate technologies 
for developing countries 83,96–99, and specifically for LRHCs 69,71,100–102. 
2.4.2.2 Evaluating PD 
PD is a diverse field and the concept is interpreted, implemented and reported on differently 
between and within industries. To evaluate use of it, practitioners recommend using 
frameworks, which elucidate what the essential aspects of PD projects are. A number of 
these have been developed 92,98,103,104. Of these, the PartE framework was selected to review 
use of PD in global health technology design 104 because it offers a number advantages over 
others. Created by technology designers, but using rigorous qualitative methods, it is 
systematic and balances the focus of the evaluation between inputs, the process itself and 
outcomes, while others focus purely on outcomes 98,105. The developers also engaged in an 
evaluation process to refine and increase the validity of the framework.  
The framework splits PD into dimensions, shown in Figure 5. A PD project may display one 
or many attributes within each dimension. For example, the Objective dimension of a PD 
project could have three attributes: designing ‘Material Things’ (such as a rice-seeder for 
visually impaired community members in rural Cambodia 98); changing  ‘Organisation, Rules 
and Information Flows’ (such as ensuring those community members continue to present at 
community meetings and influence decision-making 98) or changing ‘Mind-sets and 
Paradigms (such as changing how people with disabilities are viewed by themselves and the 
community 98).  
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Figure 5: PartE framework 104 for evaluating PD initiatives. Adapted from source. 
Others recognised formally searching literature concerning development of technologies for 
LRHCs yields limited results, and that PD is a central focus of few studies 69,71. Therefore the 
next sections use the PartE framework to structure a broad reflection on the involvement of 
users and other stakeholders from LMICs specifically in the process of developing 
technologies for LRHCs to learn about PD in this industry. Three types of studies contributed 
to this. The first are case-studies, typically reflecting on a single experience of designing a 
technology 101,102,106,107. A second type details an approach to developing technologies for 
LRHCs, typically developed by a research collaborative or established health technology 
developer, reflecting on learning across multiple projects 58,69,108–110. The third type reviews 
projects from multiple research groups and other innovation hubs targeting LRHCs, in the 
form of a systematic or informal review 69,71 or via qualitative study with experts 31,100. 
2.4.2.3 Objective of PD in designing technologies for LRHCs 
The Objective of involving stakeholders is most frequently optimisation of the health 
technology, falling into the Material Things attribute. Through working with stakeholders in 
LRHCs, innovators aim to reduce costs or improve alignment of devices to LRHCs 58,71,100–
102,106–108. Studies with additional objectives in the Organisation, Rules and Information and 
Mind-sets and Paradigms attributes argue that involving stakeholders purely for this is 
inefficient in this context. Hussain et al. 102 proposed that PD processes should prioritise the 
product and psychological empowerment of participants equally. They, and others, argue 
that for technologies to sustainably reduce global inequities in healthcare and be acceptable 
to poor and marginalised communities, other objectives are important: developing and 
linking up local human capacities to support technologies (such as training providers, 
manufacturers, biomedical technicians and innovation hubs) 58,69,108–110, changing existing 
perspectives on appropriate technologies for LRHCs 69,109 and empowering local champions 
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to innovate, drive and campaign for their scale-up and implementation 58,69,102,108–110. This is 
a common perspective of studies built upon the experience of designing and implementing 
multiple technologies. 
2.4.2.4 PD Practice in designing technologies for LRHCs 
The Practice dimension focuses on practical methods for involving participants in design, 
which could be Well-known, Emergent or Novel. Again, most studies sit within the first 
attribute, using Well-known formats of participation like interviews 58,69,71,100,102,108, focus 
groups 69, questionnaires 58,100,107,108, and clinical observation 69,71,100,101,110, especially in early 
design process stages. Cultural probes, outcome-driven innovation 101 and design 
ethnography 110,111 were also used to elicit contextual information from stakeholders. 
Prototype making is used infrequently in early stages 100,102, but prototype evaluation is 
common in later stages 58,69,71,100–102,107–109.  
Authors rarely mention Emergent, or context-adapted methods, but some elicited more 
useful findings by briefing or training multidisciplinary stakeholders on design methods prior 
to using them 69,100,101. To overcome language barriers, authors found visual and physical aids 
(such as sketches and prototypes) and situating the device within the context (using 
sketches, storyboards and role-playing) useful 69,100. Notably, one author designed 
‘Participatory Cards’, enabling participants unfamiliar with drawing to build sketches 69. 
Overall, the lack of Novel and Emergent methods used seems strange. Evidence shows that 
poor and marginalised communities disproportionately lack adequate healthcare 3,69, and 
deep understanding of these contexts is crucial for successful technology implementation. 
Novel methods help ensure all participants, regardless of education, language and social 
status can participate fully in the design process, and hence ensure their healthcare needs 
are met, but have not been explored. 
2.4.2.5 PD Interaction in designing technologies for LRHCs 
Interaction refers to how PD practitioners and participants exchange and generate 
knowledge. Attribute ‘a’ implies a one-way information transferral from participants to 
designers, but attribute ‘b’ describes stakeholders working as a team, recognising their own 
place among others in achieving project aims. In attribute ‘c’ participants are truly equal 
stakeholders in the design process, contributing and collaborating proactively and 
independently 104. Overall, this dimension is difficult to assess since stakeholders are not the 
focus of many studies and it is unclear what individual contributions they make. However, 
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Interaction between stakeholders within the studies can be inferred from the Practice 
dimension.  
The most popular methods – questionnaires 58,100,107,108, interviews 58,69,71,100,102,108 and 
observation 69,71,100,101,110 – all inherently generate one-way information flows, from 
participants to designers. Stakeholders are often involved to identify healthcare needs, 
collate information on contexts unfamiliar to designers and develop design requirements 
that represent stakeholder needs 80,100,101,107. These initial activities are considered the most 
PD important stage, since participants can exert the most influence over the resulting device 
100,112. In later design stages, stakeholders evaluate concepts, however methods such as 
surveys and questionnaires again indicate this is a one-way information flow 71,107.  
Some studies argue that involving participants throughout the design process as equal 
partners significantly increases the value of their contributions 58,69,102,108–110. In fact, many 
consider bi-directional information flows, where participants contribute openly and co-
create solutions, necessary to ensure sustainable technology implementation in LRHCs 
58,102,108. In the design of the frugal Pre-Pex device, now used at scale in district hospitals in 
Rwanda, Mody et al. 58 noted that strong the partnerships with local clinicians and 
institutions formed by involving them in every design process stage engaged the interest 
and creativity of local participants in implementing the device, which could affect their 
motivation to remain and solve further challenges in LRHCs.  
2.4.2.6 Barriers to PD in designing technologies for LRHCs 
The Barriers dimension intuitively refers to impediments to implementing PD initiatives 104. 
In global health technology design, authors frequently cite a lack of sustainable funding to 
access stakeholders in LRHCs. This barrier has both Economic and Environmental attributes 
– design teams commonly live on different continents to the settings they are designing for, 
which can be remote 100,102, and justifying large travel expenses to interact with participants 
is challenging 69,100,102. One designer expressed that if not for Economic Barriers, they would 
like user input into every design decision 100, and others relied on students volunteers due 
to finance constraints, causing issues when they prioritised or finished their studies and 
dropped out 100,108. Mody et al. 58 highlighted that local infrastructure could be another 
Environmental PD barrier, especially in collaborating with local manufacturers, who were 
limited by unreliable supply chains and distribution channels.  
Possible Political Barriers include lack of institutional boards in LMICs to review clinical 
studies which adds risk to conducting them with participants in LRHCs 58, and obtaining the 
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buy-in of multidisciplinary participants, from users to policy-makers, with different ideas and 
objectives 69,100. However Holeman and Kane 69 see this as intrinsic to the need for PD, 
because through collaborating as equal stakeholders both the product and these different 
perspectives can be adapted simultaneously until they converge into a universally 
acceptable solution. Social Barriers to participation often only became evident when, like 
this, participants worked together over extended periods. Hussain et al. 102 noticed that 
social structures could hide voices, for example, when children defer to parents opinions. 
These participants can make valuable contributions, as discovered by Gheorghe 101 when 
evaluating individual diaries that clinical staff filled in (a cultural probes method). These 
participants did not contribute in front seniors but provided invaluable insights when asked 
privately. Language Barriers also caused misunderstandings and important factors to be 
overlooked, even when translators were used 102.  
Finally, Individual Barriers to PD mostly centred around clinical participants having busy, 
unpredictable schedules, and even ‘burning out’ 69,100,101. According to some designers, their 
frustrations using low-fidelity prototypes or with the progress of designs stemmed from 
their lack of design process experience of Individuals 100. Overall, no studies directly asked 
participants what Barriers to PD they experienced, so, as with the other dimensions in the 
framework, these Barriers represent the designer’s perspective only. 
2.4.2.7 Representation of PD participants in designing technologies for LRHCs 
Representation encourages reflection on which stakeholders are recruited and their ability 
to influence PD decisions. In attribute ‘a’ one stakeholder attempts to represent the 
interests of many without their explicit permission, in ‘b’ individuals represent themselves 
and in ‘c’ a representative has explicit permission to represent others, whether voluntary or 
enforced (paid) 104. The Representation of stakeholders in decision-making was difficult to 
ascertain in almost all studies. 
Again, the popular methods of interviews, questionnaires and observation to involve 
stakeholders suggests they were able to inform decisions, but were infrequently involved in 
the decision-making process itself 71. For example, stakeholders are often asked to evaluate 
prototypes, but rarely to create or change them themselves, or to select final concepts 100. 
Sometimes this falls into attribute ‘c’ Entrusted or Delegated Representation: by 
participating in an interview or workshop, the interviewee gives permission for the 
interviewer to represent their voice in decisions 101,107.  
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Observation, however, comes under attribute ‘a’ because the participants lack a voice in 
what information is recorded or how it is construed 110 so the observer Appropriates that 
stakeholder’s voice in decisions. Another study interviewed ‘proxy users’ from HRHCs 
instead of stakeholders working in LRHCs to inform design decisions: another example of 
attribute ‘a’, and something they found problematic since proxy users held different views 
to users in LRHCs 100. When Representation falls into this attribute, PD is not necessarily 
democratic and becomes subject to the designer’s biases. Appropriating participant’s 
experiences from texts or experts can smooth-over important factors 69. One study argued 
that in the complex design context of global health technologies, it cannot compensate for 
embedding the everyday experience of stakeholders into the design process, which truly 
grounds the product in local contexts 69.  
There are also examples of the final attribute, Direct, Autonomous Representation. In two 
studies, ‘core teams’ of collaborators involved clinicians and biomedical engineers from the 
target LRHC, suggesting they directly influenced decisions 108,109. In another, participants 
created their own designs, which were transformed into higher-fidelity prototypes by the 
designer  to achieve participant priorities 102. Again, Holeman and Kane 69 consider this 
important for developing disruptive health technologies, as it ensures as many concepts as 
possible are explored without bias before a solution is agreed upon. As discussed, excellent 
FIs in global surgery often originate from innovators in low-resource contexts 81. Therefore 
this attribute of Representation in design stages such idea-generation and iterative design 
and development 66 is thought to result in more disruptive and appropriate, acceptable, 
affordable, available, accessible and quality technologies 38,69,100.  
2.4.2.3 Impact of using PD in designing technologies for LRHCs 
The final PD dimension is Impact, which could be Short-term or Small-scale Changes,  Long-
term or Large-scale Changes, or Unintended or Indirect Changes 104. Many studies progressed 
technologies through user testing 71,101,106,107,109 or formal clinical trials 58,71,100,108. Despite 
promising results, these Impacts are attribute ‘a’, Short-term and Small Scale Changes, until 
they are implemented sustainably in LRHCs. While predicting the future of these 
technologies is difficult, reviews suggest most are never implemented at scale 49,71.  
However, studies also attempted achieving Long-term and Large Scale impacts 58,69,108,110. 
Mody et al. 58 described a low-cost technology’s incorporation into the National HIV 
Prevention Strategy in Rwanda, training over 50 healthcare professionals in its use and 
engaging local teams to ensure its sustainable implementation. This work even increased 
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demand for male circumcision amongst young people. Ayah et al. 108 saw through drafting 
of novel national medical device standards and built innovation capacity and networks in 
Kenya. Evidently, Impacts must be weighed against the level of funding, and to say which 
project had the most Impact and why is not possible with the level of evidence presented in 
manuscripts. It is however, of interest to note that many Long-term Impacts identified are 
related to capacity, partnerships and skills developed innovating technologies 58,69,102,108–110. 
Holeman and Kane 69 considered these outcomes necessary to enable longer-term and 
larger-scale impact of health technologies, since they must be continually evaluated and 
updated to adapt to ever-changing needs.  
Finally, the Impact of PD on participants was only considered by one study 102, which argued 
that empowering outcomes of a design process were of equal value to the product 
outcomes, but still did not formally evaluate them. While many studies highlighted the 
importance of involving participants from LRHCs in PD 58,69,107,108, only two reflected on the 
extent they were able to participate in the design process 102,109. The ‘Global Health 
Technology 2.0’ research and development model described assessing projects on the level 
of cocreation achieved but further detail was missing 109. Hussain et al. reflected that they 
did not achieve true co-creation and participants needed training to become equal 
stakeholders. When compared to greater PD literature, the lack of evaluation any Indirect 
Impacts on participants is striking 92,98,103. It has also been argued that stakeholders should 
set aims and outcomes for measuring the Impact of innovations on target contexts 105, but 
this has not been practiced in global health technology design.  
2.4.2.7 Overall themes in PD practice  
There are certainly benefits to involving participants from LMICs in the design process such 
as improved alignment of a health technology to a LRHC 31,89 and innovative, frugal designs 
88,109, which are well-understood and sought after by PD practitioners in the field. However 
within each dimension, participation most frequently sits within the first attribute of the 
Part-E framework 104, indicating tendency towards a ‘light touch’ involvement of participants 
from LMICs. They rarely become fully integrated into the team and instead take the role of 
informants and reviewers. Whether an explicit choice, or a result of the frequently 
mentioned Barriers of funding and travel, some argue this is insufficient 101,109 and studies 
leaning towards increased participation, especially through manufacturing and 
implementation stages, see great benefit in doing so 58,69. This co-creative approach can 
remove Political and Social Barriers to collaboration, increasing democracy and rendering 
multidisciplinary participants and designers equal stakeholders in the process and product 
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58,69,102. Such projects can emerge with well-placed advocates to drive successful 
implementation of the project outcomes 98. Similar benefits have also been identified in 
wider medical device design literature 3,112,113 and the beneficial impact of sustained 
interaction and collaboration between HIC and LMIC students is recognised by biomedical 
engineering courses at universities despite high costs of transferring students 109,110,114,115. 
However, the paucity of studies rigorously evaluating participation in global health 
technology design means few conclusions can be drawn about PD in this context. While in 
wider PD literature there is evidence of such benefits and studies which rigorously evaluate 
the effect of the dimensions similar to those described in the PartE framework 92, global 
health technology design projects rarely do. Beyond anecdotal evidence, exactly which, 
when and how stakeholders are involved, and what effect this creates has not been directly 
studied. Sustainable improvement to the design and uptake of appropriate technologies and 
access to safe surgery in LMICs could make vast improvements to quality of life for the 
majority of the world’s population. To know what level of participation is right for each 
project, for the context of designing devices for global surgery and for achieving this aim, 
more rigorous evaluation of PD in global health technology design projects is needed.  
2.5 Summary  
Developing surgical technologies for LRHCs may be more difficult than conventional surgical 
technology design, since the ‘design space’ or number of viable design options is much 
reduced, due to resource constraints and fewer acceptable combinations of three variables 
(cost, robustness and maintenance) 48,116. This review established that to cope with this 
challenge, improve adoption of surgical technologies in LRHCs and increase access to surgery 
globally, they must be designed using different approaches.  
To address Objective 1 of the thesis, existing approaches to designing surgical technologies 
for LRHCs were reviewed. Significantly less experience in, research into, and guidance for 
global health technology design was identified in the literature than for conventional health 
technology design. Four design processes and two core principles addressing design for 
LRHCs were identified. Investigation revealed little evidence of design processes being 
implemented and that they are in relatively early development stages. Furthermore, the 
principles of FI and PD are interpreted and implemented differently by innovators and do 
not provide adequate structure or methods to aid in achieving the objectives they set out. 
In general, relevant projects have been criticised in systematic reviews for their diverse and 
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often poorly articulated or incomplete methodologies, lack of rigorously evaluated 
outcomes and an abundance of grey literature 49,71.  
Without the same guidance that conventional medical device designers rely on, innovators 
must currently investigate how they should design their products as well as determining 
what their design will be. To address the paucity of evidence with which to develop and 
refine recommended approaches, this work sets out to describe implementing them in the 
design of a device for gasless laparoscopic surgery and to evaluate the benefits, challenges, 
opportunities and risks incurred. In particular, to address the lack of rigour in PD evaluation 
in this context, an attempt will be made to systematically describe and evaluate 
participation, and investigate benefits for the product and participants.  
It may not be prudent or possible to set out a complete, structured design process for global 
surgical technology design. Each project must design for a different context and regulatory 
environment and may come with individual challenges and opportunities. Therefore the 
ultimate aim of this work is to begin building knowledge and evidence that innovators can 
use to predict some of these aspects, and develop proactive strategies to address them. 
Using this knowledge to mitigate project risk and increase impact of their surgical 
technologies, innovators can further improve global access to surgical care and contribute 
towards achieving UHC 2,113. 
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Chapter 3 
Design Approach 
This chapter describes the design approach pursued, providing a rationale for the main and 
supplementary activities planned for developing the design of a device for gasless 
laparoscopic surgery.  
Work contributing to this chapter was published in the International Journal of Surgery 
Global Health: 
Marriott Webb, M., Bridges, P., Aruparayil, N., Mishra, A., Bains, L., Hall, R., Gnanaraj, J., & 
Culmer, P. (2021). Designing devices for global surgery: Evaluation of participatory and 
frugal design methods. IJS Global Health, 4(1), e50 
3.1 Introduction 
The previous chapter revealed three key design approaches to the development of 
technologies for LHRCs: design processes suitable or even specifically developed for this 
design context, frugal innovation and participatory design.  
These approaches complement rather than compete with one another. In fact, in some ways 
they are indivisible. The principles of FI help innovators set design objectives and priorities 
to develop disruptive global surgical technologies, but design processes and PD provide 
means to achieve those objectives. Design processes for LRHCs encourage use of PD, but 
reviewing use of PD in this context revealed that not only is it resource-hungry and 
interpreted and implemented in different ways, but the impacts of using it are rarely 
evaluated. Advice for designers on how to specifically structure and implement PD to 
achieve desired outcomes it is needed, which design processes may be able to provide. 
Hence, it is possible and even desirable to implement the three approaches simultaneously. 
Therefore this research project explores integrating them to design a device for gasless 
laparoscopic surgery – the Retractor for Abdominal Insufflation-less Surgery (RAIS).  
Literature surrounding these approaches has been criticised for lacking clear methodology. 
Integrating them could make drawing distinct boundaries between them, and articulating 
how each has been implemented and what impact that has had, challenging. Therefore, this 
chapter aims to describe the plans made prior to designing the RAIS device for implementing 
these approaches to facilitate a structured, critical evaluation of each. 
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3.2 Planning the RAIS Design Process  
3.2.1 Design Process Selection 
Design processes can help organisations achieve greater impact with their products, and 
navigate risky and complex innovation sectors such as medical device design 30,117. To be 
effective, they must be tailored to the organisation, product and resources available 63. 
Four relevant processes to this design context were identified and compared in 2.3. With 
the aim of the wider research project being to meet the pressing clinical need within an 
ambitious timescale, investigating more than one process and comparing the designs 
developed was not possible. Therefore, based on the rationale in the following paragraphs, 
the Design for Safe Surgery Roadmap 31 was selected to structure the approach to designing 
the RAIS device.  
The roadmap (Oosting et al., 2018) is more limited in scope than design processes employed 
for HRHCs. Comparing the level of detail to, for example, the Linear Life Cycle Model 118 as 
in Figure 6, makes this evident. The roadmap describes four phases in developing a surgical 
technology, but rather than fully defining completion criteria for the phases, or mandating 
design activities to complete within them, the roadmap presents general advice and some 
relevant examples. The user must consider how these examples translate to their own 
innovation development, and plan their own activities in each phase. This is particularly true 
for the latter two phases of the roadmap, while the first two phases provide more detailed 
guidance.  
This detail scarcity forms part of the rationale for its selection over other relevant processes 
for designing the RAIS device. The process has less overhead than more complex schemes 
like Biodesign Process 67, and is thus feasible to implement as part of a small team, with 
limited timescales and resources available. These are crucial considerations for ensuring a 
design process enhances, rather than exhausts, the capabilities of an organization 117,119. It 
is also tailored specifically for designing a surgical technology in a LRHC: the precise design 
context of the RAIS device. Finally, being in the early stages of development and yet to be 
implemented widely, the roadmap needs the community of innovators in global surgery to 
use, reflect upon, and improve it. In this way its strengths and weaknesses can be established 
and its continuous evolution initiated. Evidence of its use may encourage others to 
implement and disseminate it further. Therefore, providing a detailed account and 
evaluation of implementing the Design for Safe Surgery Roadmap 31 supplemented with 
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tangible examples to demonstrate its use and impact on the RAIS design development forms 
a useful contribution towards the literature and the objectives of this thesis. 
 
Figure 6: Comparison of the Design for Safe Surgery Roadmap 31 and the Linear Life Cycle 
Model 118. Adapted from sources.  
3.2.2 Design Process Structure  
As discussed in the previous section, the roadmap does not present a complete guide to 
developing a surgical technology. This section details how the RAIS team planned and 
selected design activities within each roadmap phase. 
Firstly, the design project ambitions spanned beyond the scope of the roadmap: past 
prototyping and testing; into manufacture, application for regulatory approval and clinical 
trials in India. Therefore an additional ‘Design to Manufacture’ phase was included, as shown 
in Phase 4 of Figure 7. Some organisations may involve manufacturers earlier, perhaps to 
create prototypes in Phase 3, and therefore design to manufacture may not constitute a 
distinct phase in every design process. However the RAIS team could utilise in-house 
prototyping capabilities, so manufacturer involvement was purposefully delayed until 
clinicians had tested and approved the design. This would facilitate rapid changes to 
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prototypes and iteration throughout Phase 3 of the roadmap. With advancements in and 
reduced costs of rapid prototyping 120, this is feasible for many organisations.  
 
Figure 7: The RAIS Design process, developed using the Design for Safe Surgery Roadmap 31 
and principles of Frugal Innovation and Participatory Design 
3.2.3 Integrating Participatory Design and Frugal Innovation 
The team used the principles of PD and FI to guide activities within the roadmap, as 
described in the following sections. 
3.2.3.1 Frugal Innovation 
While there are few specific methods for designing FIs, they must meet three criteria: 
substantial cost reduction, focus on core functionality and optimised performance level 76. 
Co-creating with users is recommended 79, as well as prioritising numerous frugal 
characteristics 86.  
Aspects of FI must be considered in every design phase. In Phase 0 of the roadmap, a 
pressing surgical need should be identified. FIs can improve surgical care globally 81, and this 
potential to create large-scale impact should be considered when selecting a need to 
address in order to create maximum impact on global surgical care. In Phase 1, the innovator 
develops an understanding of LRHCs. Understanding users is a key component of this, and 
FIs must optimise value for them 79. Therefore the data collected in this phase is crucial to 
innovate frugally. FI also sets key design priorities, such as low cost and robustness 76,86, and 
therefore must be considered when setting requirements in Phase 2. To achieve an 
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optimised functionality and performance level 76, one should work closely and iteratively 
with local stakeholders 79, which is the basis of Phase 3. Finally, to keep costs low, 
consideration of manufacturer capabilities and supply is essential, and therefore focus on FI 
must be maintained throughout Phase 4 76,121. Hence consideration of FI was planned in 
every phase of the RAIS design approach, shown in Figure 7.  
3.2.3.2 Participatory Design 
Reviewing use of PD in technology design for LHRCs revealed most organisations took a ‘light 
touch’ approach to each Part-E framework dimension 104, and that participation occurred 
mostly in initial and evaluation design phases. However, some studies highlighted benefits 
to involving participants throughout the design process (see 2.4.2). 
Experience of the GHRG-ST in LRHCs in Northeast India indicated that the design team would 
be unfamiliar with the context. Peer-reviewed literature concerning gasless laparoscopy is 
also relatively scare also provided limited useful information for designers 122. However, the 
GHRG-ST had developed links with surgeons based in India who were passionate about and 
working to disseminate the technique more widely. Considering these challenges and 
opportunities, the team decided participation should be maximised. In terms of the Part-E 
framework, this meant focusing on overcoming Barriers to PD, and targeting attributes such 
as Direct and Autonomous in the Representation dimension, and ‘Collaborative 
Contributions’ in the Interaction dimension. The Objective of using PD would be to design 
the RAIS device, falling into the Material Things attribute, and the prior experience of the 
team working with participants suggested Well-known formats of Practice would be 
appropriate, since all participants were qualified clinicians and all team members spoke 
English as a common language, reducing the difficulty of overcoming commonly-cited Social 
and Political PD Barriers such as differences in language or education 104.  
Therefore plans were made to integrate PD into every roadmap phase (see Figure 7). This 
approach would also facilitate investigation of what value involving participants in a 
‘thorough, sustained’ approach might add for an organisation, participants, and the resulting 
technology, by evaluating the PD outcomes for intended Short-term and Long-term Changes 
(see Chapter 4), as well as Indirect and Unintended Impacts (see Chapter 5) 104.  
3.3 Method Selection 
In this section, the methods selected by the design team to guide work within each phase of 
the roadmap are discussed. 
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3.3.1 Phase 0: Identify a Need for Surgical Equipment 
The roadmap advises considering local knowledge of end-users when selecting a need to 
address; a sentiment echoed by PD and FI practitioners 69,79. The need to develop a new 
device for gasless surgery was identified using the findings of primary research and literature 
reviews conducted by the GHRG-ST 123. The primary research comprised of dialogue with 
stakeholders in LRHCs in Northeast India and involvement in their work to train rural 
surgeons in gasless laparoscopy 124. On a thorough review of the need to improve the 
technology supporting this surgical technique, underpinned by consultation with local 
stakeholders, the team resolved to address it. 
3.3.2 Phase 1: Understand the Context of Global Surgery 
In this phase, the roadmap suggests using qualitative methods to gather information on key 
aspects of the LRHC of interest presented by the roadmap, or to populate existing 
frameworks created to aid innovators in defining the context 125.  
With little peer-reviewed information on the context available, the team planned qualitative 
research to obtain the required design information. This paucity of existing data introduced 
some risk into the design process since there was little to verify the team’s findings against. 
Several measures were planned to mitigate this risk. Firstly, the team reviewed the 
important contextual aspects described by the roadmap to develop appropriate interview 
questions 31. While online interviews were one option, others have found engaging users 
with devices in a simulated or real environment of use can elicit more active contributions 
and useful information from them 100. Therefore interviews, surgical observations and group 
discussions in the design context were planned. The team were still concerned about 
overlooking key contextual factors or assigning non-representative value on them based on 
input from limited user, but to mitigate this possibility PD was planned in later design phases.  
After reviewing suitable methods for summarising the contextual findings from 89,125, a 
regularly-updated  parameter diagram (p-diagram) was selected. P-diagrams are used in 
‘Robust’ or ‘Six-Sigma’ Design 126. In other design contexts, the tool is often used in early 
design phases to capture system details: the inputs, design controls, ideal functions, ‘error 
states’ and variations which could affect system performance 126. The system within which 
the RAIS system must perform (in a low-resource operating theatre) is complex and can vary 
significantly, so the p-diagram was considered appropriate to capture data collected from 
qualitative methods concerning required device functions, design inputs, uncertainties and 
known failure modes (such as experiences of the device obstructing surgery, causing patient 
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harm, or being unavailable to rural surgeons). Hence, the P-diagram could be used to 
construct a holistic view of the design challenge for the designers to refer to, and also to 
initiate consideration of risk, safety and device quality, providing a basis for future 
documents used in regulatory submission, such as FMEA 30. 
Hence, planned activities in this phase, which aims to answer a number of questions on the 
surgical context, comprised primary qualitative research, sustained participation of clinical 
stakeholders and use of a P-diagram. 
3.3.3 Phase 2: Determine the Implementation Strategy and Design Requirements  
After understanding the clinical need and context, an implementation strategy and series of 
design requirements should be developed. To guide innovators in this phase, The Design for 
Safe Surgery Roadmap 31 provides example requirements and implementation strategies for 
a global surgical context. It does not advise on how to approach selecting the right 
requirements or strategy for the technology. Therefore, methods of developing these were 
selected by the design team based on prior experience, with the aim of integrating the 
principles of PD and FI into the phase. 
Developing accurate requirements is essential to design safety and greatly influences the 
product development 127. Developing a feasible implementation strategy requires 
consideration of team resources, including those available to the clinical participants. 
Therefore, it was considered necessary to convene a workshop to collaboratively agree on 
requirements and an implementation strategy with clinical participants local to the design 
context. Others have shown that involving users in the early stages of design for LHRCs 
increases their influence on the design 71 and that well-planned workshops can be effective 
in elucidating relevant contextual information and engaging the creative capacity of 
participants 69,100,128. Ensuring they could represent themselves in decision making was also 
intended to help achieve the desired attributes within the Representation and Interaction 
dimensions of PD. The p-diagram would be used to summarise the requirements and 
additional information on the design context generated in this session.  
Hence, activities in this phase were centred around one, day-long workshop and use of a P-
diagram to summarise outputs. Since the Barrier of geographical distance separated the 
clinical participants and design team, plans were made to maximise this opportunity to 
collaborate in person. Since stakeholders in LMICs often have the most innovative frugal 
ideas 121, the workshop would also be used to initiate Phase 3 of the design process by 
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brainstorming, selecting and refining concepts for the device with the participants. Further 
Phase 3 activities are discussed in the next section. 
3.3.4 Phase 3: Act  
For this iterative phase of design, prototyping and testing, the roadmap provides little 
advice. While co-creation with local stakeholders in recommended, how and to what extent 
this should be enacted is not discussed. Therefore the team selected an established model 
used in conventional medical device design to augment this phase: the waterfall model 129. 
Reflecting on the importance of ensuring the safety of surgical innovations for LHRCs, the 
design team selected this approach to structure Phase 3 to support ensuring all design flaws 
and risks to patient safety were recognised and addressed prior to application for regulatory 
approval and clinical trials. The model, shown in Figure 8, addresses this by structuring the 
technical development process with iterative design verification and validation 129. 
Alexander and Clarkson 130 defined verification and validation:  
“Verification… is concerned with ensuring that, as the design and 
implementation develop, the output from each phase fulfils the 
requirements specified in the output of the previous phase…” 
“Validation… is concerned with demonstrating the consistency 
and completeness of a design with respect to the initial ideas of 
what the system should do” (p. 197) 
With the aim of achieving a safe and controlled design process which embeds PD, the 
waterfall model was used to develop a verification plan, where LMIC-based clinical 
participants could discuss, evaluate and ideate concepts in regular, structured stages. These 
opportunities would largely take the form of online meetings due to geographical distance, 
but one in-person visit to assess a physical prototype was also planned. 
 













- 32 - 
The waterfall model also contains a validation step. Validation of medical devices designed 
for LRHCs must be carried out in those settings. As discussed in 2.1.3, the nuances of LRHCs 
affect technology performance. Therefore, testing in that context may reveal insights critical 
to the safety, performance and feasibility of implementing a technology there 22,58 and 
medical technologies must be tested with end-users in a context which represents the true 
context of use. However, this incurs additional considerations 22. Low-resource centres can 
be far apart and operate on minimal staffing, making it resource-intensive to involve large 
numbers of users in validation. Therefore plans to take advantage of an opportunity for the 
design to be tested by a numerous end-users at a rural surgery conference in India were 
made 131. If the final design was positively received by end-users this would be an end-point 
to the ‘Act’ phase. It also provided an opportunity to assess the design process was in 
producing a concept that met the requirements of end-users and target context. 
Activities in this phase therefore comprised of a brainstorming workshop and structured 
prototype verification and validation opportunities, all of which involved clinical participants 
from LMICs. 
3.3.5 Phase 4: Design to Manufacture 
This phase was defined by the design team, since it surpassed the reach of the roadmap. In 
2.1.2, barriers to the uptake of technologies in LRHCs were identified, such as access to spare 
parts, maintenance and repair services. Access to these is largely influenced by the 
manufacturer, and to overcome these barriers innovators should work with local 
manufacturers 51,58,108. Following these recommendations, plans for this phase included 
selecting an in-country manufacturing partner with an understanding of LRHCs and the need 
for access to spare parts and repair in remote areas, as well as experience in local regulatory 
processes for medical devices.  
Therefore activities planned in this phase included involving local clinical participants in 
identifying an in-country manufacturing partner, and working closely with them to produce 
a series of prototypes for iterative evaluation and refinement by clinical participants. 
Through discussion, collaboration and compromise between designers, manufacturers and 
clinicians, the aim of the phase would be to arrive at a design feasible to manufacture at a 
frugal cost and quality, whilst satisfying the requirements agreed in Phase 2 and meeting 
approval criteria set out by regulatory authorities for use in clinical trials. 
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3.4 Summary  
This chapter addressed Objective 2 of the thesis by planning the implementation of selected 
design approaches to design the RAIS device for gasless laparoscopy.  The methods utilised 
to implement the approaches were articulated in detail. 
Overall the roadmap provided invaluable structure to plan the design approach and establish 
what resources might be needed at each stage. It also provided sufficient detail to help select 
methods and plan activities within Phases 0 and 1. However, the team found the roadmap 
provided little advice for approaching Phases 2 onwards. Of course, to make best use of the 
different resources, experience and opportunities available to specific organisations, the 
flexibility of the roadmap may be appropriate 59,63. However the designer is left to compare 
a large number of design tools and methods available with little guidance on which might be 
helpful in this context, which can be a significant task. In this instance, the P-diagram 118 and 
waterfall model 132 were selected by the design team based on prior experience, but it is 
likely that many other, and potentially more appropriate, design tools could be substituted 
in their place. In these phases, considering the principles of PD and FI and provided more 
guidance on selecting rational design methods and strategies for this context.  
This chapter laid foundations for a detailed evaluation of the usefulness of the approaches 
selected and how their use affected the RAIS design, which follows in the next chapter. An 
evaluation of the implementation and outcomes of these approaches will provide evidence 
useful for developing and refining them. 
- 34 - 
Chapter 4 
Evaluation of the RAIS Design Development 
Using the integrated design approach described in Chapter 3, with the extended ‘Design for 
Safe Surgery Roadmap providing an overarching structure to the process, the team designed 
a lift device for gasless laparoscopic surgery. In each design process phase, this chapter 
discusses the challenges, benefits and opportunities identified implementing the selected 
approaches. Through evaluating their impact on the RAIS device design, the chapter aims to 
provide evidence which can be used to further develop and refine these approaches for 
innovating global surgical technologies.  
Work contributing to this chapter was published in the International Journal of Surgery 
Global Health: 
Marriott Webb, M., Bridges, P., Aruparayil, N., Mishra, A., Bains, L., Hall, R., Gnanaraj, J., & 
Culmer, P. (2021). Designing devices for global surgery: Evaluation of participatory and 
frugal design methods. IJS Global Health, 4(1), e50 
4.1 Introduction 
In this chapter the design activities and outcomes within each of the Phases 0-4 of RAIS 
design process (see Figure 7) are discussed. The insights and challenges gained through 
implementing each phase and through integrating PD and FI into the approach are 
described. The text in sections 4.2 - 4.6 contains this narrative and critical evaluation. To 
provide an overview of the process, an annotated timeline (see Figure 9 for overview, and 
Figure 10 for detail) of the design Phases 1-4 is provided, highlighting the iterative evolution 
of the RAIS device. 
 
Figure 9: Overview of design process activities and RAIS design development (low detail 
level)
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Figure 10: Timeline of design process activities and 
RAIS design development (high detail level) 
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4.2 Phase 0: Identify a Need for Surgical Equipment 
4.2.1 Phase Activities 
As described in 3.3.1, primary research, literature reviews and consultation with local 
stakeholders and end-users in Northeast India, conducted by members of the GHRG-ST, 
comprised this phase 14,22,23,123.  
4.2.2 Phase Outcomes 
From the phase activities, both the compelling clinical need and a potential solution was 
identified: to improve the provision of laparoscopic surgery for patients in remote areas of 
Northeast India using gasless laparoscopy, facilitated by AWL devices. Research to identify 
the clinical need informed the team on the ‘Surgical Barriers for patients in LMICs’ 31 and 
how they might be overcome using gasless laparoscopy. In Northeast India, use of surgical 
services is positively correlated with proximity to the service and financial status of patients 
123. Conventional laparoscopy via pneumoperitoneum is expensive, largely due to equipment 
costs 133,134, and facilities offering it are typically far from patients in remote areas. Gasless 
laparoscopy has potential to both significantly reduce costs and enable laparoscopy in 
remote facilities, while retaining the key benefits of conventional laparoscopy for patients 
14,122.   
Hence, gasless laparoscopy satisfies two FI criteria. Compared to conventional laparoscopy, 
it offers a substantial cost reduction, whilst affording patients the same, or even increased 
benefits 122. However, its disruptive potential has not yet materialised. Stakeholders 
discussed several aspects which limited its wider adoption, including the third criteria for FI: 
the performance level of current AWL devices. Despite iterative improvements made 135 
these require further development. Therefore, with the support of local stakeholders 
involved in disseminating the gasless technique, the design team resolved to redesign the 
AWL device.  
4.2.3 Phase Evaluation 
In this phase, the roadmap proved useful to the design team, who on its advice, identified 
the need through consultation with local stakeholders. The team also found an 
understanding of ‘Surgical barriers for patients in LMICs’, which in the roadmap is not 
explored until the next phase of development, was instrumental in selecting this need over 
others, because of the solution’s potential to overcome these barriers and increase surgical 
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access in LRHCs, which is central to the GHRG-ST’s aims (see Chapter 1). The FI principles 
also influenced need selection. There are many surgical needs in LRHCs, so the team chose 
to target one with a potential solution meeting the frugal criteria, with aim of achieving 
disruptive surgical care improvement 76. Establishing the focus on PD at this early stage was 
useful too, as the design team could identify and begin discussions with potential 
collaborators.  
While the advice presented by the roadmap in this phase is useful, considering aspects of 
PD, FI and the next phase of the roadmap helped the design team to select this need. While 
the roadmap highlights some FIs in the introduction, it does not reference what criteria can 
be used to identify them, which the team found useful in this phase.  
4.3 Phase 1: Understand the Context of Global Surgery 
 
4.3.1 Phase Activities 
As described in 3.3.2, the design team planned qualitative methods such as interviews, focus 
groups and observation to research key aspects of the surgical context 31.  Surgeons 
performing gasless laparoscopy in Northeast India are few in number and typically work in 
remote locations 23 so performing these posed a challenge. The design team identified an 
opportunity to interact with a relatively large number of end-users during their attendance 
at a gasless laparoscopy training course 124.  
Product designers performed ten individual, semi-structured interviews with attendees, 
examiners and facilitators at the event. They observed four live surgical demonstrations of 
the technique and culminated the research with a group discussion (see Activity 1, Figure 
10). Throughout these interactions, they identified stakeholders interested in being involved 
further in the design project as participants. Then the compiled contextual information, 
informally collected as notes, videos, pictures, sketches and transcripts was presented to the 
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newly formed team including clinical participants. This team distilled the information into 
the p-diagram, discussed in the following sections.  
4.3.2 Phase Outcomes 
The contextual information collected is summarised as the ‘Inputs’, ‘Sources of Variation’ 
and ‘Error States’ components of the P-Diagram (see Figure 11). 
 
 
Figure 11: Contextual Insights gained during Phase 1 of designing the RAIS device, 
summarised as the ‘Inputs’, ‘Sources of Variation’ and ‘Error States’ of the RAIS device 
p-diagram 
4.3.2.1 P-Diagram: Inputs  
Interviews with end-users revealed that to operate using an AWL device, the minimum 
required inputs are a patient, a surgeon with laparoscopic training, at least one operating 
theatre (OT) assistant and sterile OT with certain equipment available. These formed the 
‘Inputs’ section of the P-diagram in Figure 11. 
4.3.2.2 P-Diagram: Sources of variation 
The ‘Sources of Variation’ section was populated with factors considered likely to vary and 
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aspects within the ‘Structures of the Healthcare System’ component of the context 31 
revealed insights about different surgical environments and the technologies and resources 
available to them. For example, end-users highlighted that their Operating Theatre Tables 
(OTTs) could be donated or bought second hand, and conformed to various national 
specifications. While they couldn’t provide details of these, their input catalysed further 
useful data collection. Figure 12 details the results of the team’s research on the dimensions 
of OTT accessory rails by country of manufacture.  
“Personally, I use autoclave… know of others who use chemical solution” 
“Locking system needs to be universal as tables differ” 
“Bed widths differ” 
 
 
Figure 12: Variation in OTT Accessory Rails 136 
Another ‘Source of Variation’ interviews revealed was how much end-users might use and 
maintain the device, affecting its wear over time. In some instances end-users had no 
biomedical staff or formally trained OT assistants to assist with device maintenance.   
“Lots of operations in a day” 
“It needs to be portable so you can take it to pop-up surgeries” 
“Maintenance is carried out as and when needed” 
4.3.2.3 P-Diagram: Error States 
The ‘Error States’ section was populated with ways in which the device could fall short of 
the requirements of the end-users and LRHCs 42. Error states relating to ‘Structures of the 
Healthcare System’ 31 were also identified during interviews. Discussing factors that might 
prevent users from purchasing technologies revealed new insights. While some explained 
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they could only purchase the cheapest technologies available, others thought hospitals 
would invest in ‘attractive’, well-made and robust technologies. 
Further error states relating to ‘Aspects of Safe Surgery’ 31, were elicited by asking new end-
users to review an existing AWL device as experts trained them to use it on a simulated 
abdominal wall. New users highlighted the size and weight as a barrier to them transporting 
it easily and sterilising it using small ‘flash’ autoclaves. Instead a nurse would need to scrub 
the device by hand using harsh chemicals. Experienced users explained that its size also 
made it difficult to store sterile, and without a dedicated case, it was usually stored wrapped 
in drapes - something new users hadn’t yet considered. While new users were pleased the 
existing device seemed difficult to damage, experienced users highlighted issues with joint 
wear, which sometimes slipped or became stuck. 
More error states materialised through observation, supplemented with sketching and 
discussion. For example, while end-users were achieving an operable view during live 
surgery, the designers observed device adjustment required multiple assistants. When 
prompted, end-users revealed that the lifting handle was non-sterile and the sterile position-
locking lever was out of the surgeon’s reach, so getting an operable view required co-
ordination of sterile and non-sterile assistants. Since many had few trained assistants who 
were usually needed elsewhere, this was frustrating. End-users also drew annotated 
sketches of the surgical instrument positioning for different operations to show how the 
device could obstruct surgical tasks. These ‘error states’ highlighted potential safety issues 
and opportunities for RAIS to increase value for the user. 
4.3.3 Phase Evaluation 
4.3.3.1 Design for Safe Surgery Roadmap 
The Design for Safe Surgery Roadmap provided useful guidance to structure phase activities, 
giving detailed information on key research topics such as aspects of safe surgery and the 
healthcare system structure 31. Our experience confirmed the proposed research methods, 
such as semi-structured interviews and site visits, were appropriate for a high-level mapping 
of the context and gaining novel insights into the research topics discussed. However subtle, 
but crucial insights were identified by augmenting interviews with sketching, handling 
existing equipment and observing live surgeries. These techniques were especially useful for 
identifying error states: an important first step towards ensuring the quality, safety and 
enhanced value for users of RAIS in a LRHC. 
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End-users also offered diverse information and opinions about the LRHCs they operate in, 
highlighting the importance of obtaining multiple perspectives at this early stage. Hearing 
diverse perspectives from new and experienced end-users, as well as technical staff, was 
critical. This was facilitated by attending a training camp, which ultimately provided 
excellent interactive information-gathering opportunities for designers. The team reflected 
on the importance of being resourceful and innovative in data collection methods in this 
context and felt the roadmap could provide advice on or examples of this. Others have 
identified similar opportunities to obtain input from multiple remote end-users, such as 
conferences or surveys (R. Oosting et al., 2020).  
A final suggestion for roadmap enhancement would be to investigate ways of summarising 
and presenting the data collected in this phase, which can be extensive. The P-diagram was 
useful for preparing the knowledge for translation into an appropriate design, but other 
methods could be even more suitable.  
4.3.3.1 Participatory Design 
In this phase Interaction with stakeholders mostly constituted ‘Contribution of Resources 
and Information’. However the data volume collected meant that some aspects of the 
context were overlooked or misinterpreted. At this stage both end-users and designers were 
unaware of what knowledge was relevant for designers. Therefore this phase also 
highlighted inadequacy of such Interaction and the importance of local stakeholder 
participation throughout all roadmap phases to continue progressing contextual 
understanding. Collecting data through qualitative methods in this phase provided an ideal 
opportunity to identify stakeholders interested in participating further. 
4.3.3.2 Frugal Innovation 
Activities in this phase revealed opportunities to increase the value of RAIS for end-users 
and enhance its frugality. However, while a broad overview of the context was obtained, the 
methods employed did not help quantify variation within it, which is necessary to optimise 
innovation performance, functions and cost (the frugal criteria) 76. While qualitative 
methods are excellent for uncovering unknowns they can become unwieldy when used to 
collect quantitative data. Therefore these activities were more appropriate identifying areas 
where quantitative data may be needed for frugal optimisation than for collecting the data.  
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4.4 Phase 2: Determining Design Requirements and Implementation 
strategy 
 
4.4.1 Phase Activities 
The team planned building the requirements and implementation strategy as a collaborative 
process. Participants identified during Phase 1 convened with the design team for a day-long 
workshop to translate information gathered in Phases 0 and 1 into the Phase 2 outputs (see 
Figure 10, Activity 2). 
Team resources, feasible timescales and contextual information were discussed to elucidate 
potential opportunities and challenges in implementing the device, and a high-level 
implementation strategy developed. Then product designers presented the contextual 
information gathered in Phase 1. Reflecting on the frugal principle of core functionality-focus 
76, the workshop attendees listed the minimum and ‘ideal world’ device functions separately 
to understand which were essential, and which should only be included if they increased 
value for users significantly. All were summarised in the ‘Ideal Function’ P-diagram section 
(see Figure 13). The workshop concluded with product designers leading a brainstorming 
session, where all participants were encouraged to generate original, ‘blue sky’ design ideas, 
which were sketched, broken down and then dismissed or developed further collaboratively. 
Using these quick-fire concept reviews the team formalised the design space into ‘Control 
Factors’ for the P-diagram (see Figure 13). 
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Figure 13: Requirements developed and results of group solution brainstorming, 
summarised as the ‘Design Control Factors’ and ‘Ideal Function’ of the RAIS device P-
diagram. 
4.4.2 Phase Outcomes 
4.4.2.1 Implementation strategy 
The agreed implementation strategy targeted remote areas because of their current inability 
to offer laparoscopic surgery and the enhanced benefits it offers for daily wage labourers. 
Research revealed laparoscopic training is limited in this setting, which the strategy 
reflected: the device would need to be implemented alongside training, likely to be funded 
by grants. Local stakeholders agreed that device cost reduction could facilitate them training 
more surgeons to further disseminate the technology. Visibility and awareness of the 
technology was also identified as a limiting factor in its adoption. Local stakeholders also 
advised providing more evidence of its effectiveness and feasibility in remote settings was 
needed, which they were well-positioned to investigate. Therefore identifying partners to 
collaborate with concerning training and dissemination of gasless laparoscopy also became 
central to the implementation strategy. 
4.4.2.2 P-Diagram: Ideal Function 
Following a review of the contextual information and implementation strategy, the team 
agreed on 18 minimum functional requirements for RAIS and 4 additional ‘desirable’ 
requirements. For example, a functional requirement for RAIS to ‘provide a view equivalent 
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to laparoscopy via pneumoperitoneum’ was introduced as a result of the implementation 
strategy. To tackle the challenge of increasing global visibility of gasless laparoscopy, the 
device needed to address concerns currently limiting uptake of the technology such as 
limited operating field of vision 137–139 and high training requirements 140. The four ‘desirable’ 
requirements were non-functional, such as ‘Incorporates retraction system for organs’. With 
no evidence of existing retraction systems being used with AWL devices, the value this might 
add for the user was unknown, but stakeholders speculated that it could reduce the issue of 
organs being ‘sucked’ towards the abdominal wall and reducing the operating vision and 
space for the surgeon (see Figure 14). Once investigated further, this requirement could be 
included or dismissed based on whether it met frugal criteria.  
 
Figure 14: Operating view and space comparison: Pneumoperitoneum vs Gasless 
The brainstorming session continued to reveal additional requirements. For example, a 
designer suggested supporting the abdominal wall weight using the ceiling or floor. Clinical 
stakeholders quickly dismissed this, explaining the surgeon had to tilt the OT to move the 
patients’ internal organs, whilst maintaining the lift and view inside the abdominal cavity. 
This became a functional requirement. The session also helped designers assign value to 
requirements and prioritise them. For example, ideas for internal components were 
discussed which could improve the view, but were mostly rejected by stakeholders based 
on their difficulty to clean, which took priority for minimising infection risks. Requirements 
could also be refined during this session: by discussing with participants exactly how they 
Pressure acts equally in all directions, 
pushing organs away from the abdominal wall
Suction created by lifting abdominal wall 
pulls organs towards abdominal wall, 
reducing space
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would transport RAIS, the ‘portability’ requirement for the device was refined to specify a 
maximum weight and dimensions to ensure it could be transported as plane hand-luggage. 
The team also developed requirements which were discovered to be inaccurate later in the 
design process. For example, to minimise equipment down-time in remote facilities the 
team set a requirement that RAIS could be repaired with basic manufacturing equipment, 
which had a significant impact on the design, but later the team learned that many remote 
areas did not have these capabilities and this aspect did not add value for them. 
4.4.2.3 P-Diagram: Design Control Factors  
With iterative, participatory dissection of the requirements and solutions brainstormed, the 
device was progressively broken down into modular components: an attachment system, an 
internal component, a frame and a lift mechanism. These became the high-level design 
control factors, and several potential solutions were developed for each. Clinical 
stakeholders generated innovative ideas in this session such as an oval-shaped and a 
rotating, double-helix version of the internal component for enhancing the view, both of 
which were developed to become a part of the final RAIS system. 
4.4.3 Phase Evaluation 
4.4.3.1 Design for Safe Surgery Roadmap 
Advice provided by the roadmap, such as to consider the implementation strategy in this 
phase because it influenced the requirements, was useful because it ensured the team 
prioritised requirements such as the surgical view. The example design requirements it 
provided were also confirmed as appropriate for the RAIS device by the contextual findings 
31. 
However, the team found the advice insufficient to decide what factors to consider when 
developing an implementation strategy, what data to collect or even how detailed the 
strategy should be. What requirements are suitable (e.g. functional, performance) was also 
unclear, or how they should be prioritised, ranked or refined. It is well known that designers 
commonly make a multitude of different errors during requirements-setting 141, and that 
requirements have a great deal of impact on what designs are produced 127,142, but there is 
little in the roadmap to help designers develop a good set of them. Overall, the roadmap 
seems to under-assign importance to this phase, which has huge influence over the resulting 
design, and provides examples rather than suggesting methods for approaching the 
activities, despite the availability of existing methods 143. 
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4.4.3.2 PD 
The PD approach helped fill gaps in the roadmap’s advice. Involving local stakeholders in 
plans and decision making for the implementation strategy invoked invaluable contributions 
from them, such as performing studies to enhance the visibility of gasless laparoscopy 14. 
Open brainstorming, sketching and discussing concepts with local stakeholders also revealed 
new contextual insights and helped assign value to requirements in a similar way to methods 
like the ‘Bollywood Technique’ 144. The emphasis placed on facilitating ‘Direct, Autonomous’ 
Representation of stakeholders, and Interactions in the ‘collaborative contributions’ 
attribute in this phase was really useful for understanding the design space further. 
Participants also had innovative ideas which enhanced the RAIS design. 
4.4.3.3 Frugal Innovation 
In this phase the ‘concentration on core functionalities’ 76 aspect of FI encouraged the team 
to identify minimum functional requirements and include or dismiss other requirements 
based on the value they added for users. To achieve the second criteria, ‘optimised 
performance level’ 76, targeted data collection is necessary and this encouraged the team to 
challenge requirements at this stage, and establish exact performance needs, such as 
specific portability requirements. During the brainstorming session, all three criteria helped 
the team select which concepts to develop further in Phase 3 76. 
4.5 Phase 3: Act 
 
Phase 3 spanned 5 months before the validation step (Activity 6, Figure 10). Activities 3, 4 
and 5 in Figure 10 show the three verification loops implemented within this phase, 
highlighting the impact input from participating stakeholders had on the RAIS design. 
4.5.1 Clinical Verification: Loop 1 
This section refers to the first iteration of the waterfall verification loop (see Figure 8). 
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4.5.1.1 Activities 
In the first verification loop (See Figure 10, Activity 3), the design input was the P-Diagram 
developed during the previous phase and ideas generated through brainstorming. The 
design process comprised of designers and engineers presenting bi-weekly updates to local 
stakeholders via video-conferencing to obtain feedback as the ideas were developed into 
Computer-Aided Design (CAD) models and low-fidelity prototypes. The feedback was used 
to iteratively improve the design. Hence, the concepts were developed into the loop design 
output: a medium-fidelity prototype containing all functional aspects of the design.  
4.5.1.2 Outcomes 
The ideas, feedback and knowledge of participants influenced the design significantly in this 
phase. For example, several joint configurations could enable the device to reach the correct 
position despite sources of variation such as bed size and patient anthropometrics. 
Presented with several options (Activity 3, Figure 10), participants selected the tubular 
telescopic design, which offered minimal obstruction and useful flexibility in device 
positioning for them. Without this input, the designers would have selected an option which 
was cheaper to manufacture or inherently stronger, but had less user value. Participants’ 
knowledge also helped identify FI opportunities. For example, the rail variation shown in 
Figure 13 made designing a lightweight, low-cost universal attachment challenging, but by 
asking participants about other accessories clamped to the rails, the designers identified that 
all OTs had lithotomy poles, attached to the table using rail clamps. Therefore the approach 
pursued was to enable users to use their existing rail clamps to attach the RAIS device, a 
solution to variation and reduced cost for users. 
4.5.2 Clinical Verification: Loop 2 
This section refers to the second iteration of the waterfall verification loop (see Figure 8). 
4.5.2.1 Activities 
In the second design verification loop (see Figure 10, Activity 4), design input was provided 
by a participating local stakeholder visiting the UK, who assessed the medium-fidelity 
prototype using a simulated abdominal wall and OTT. The design process involved a design 
team workshop to ideate solutions for addressing concerns in the user feedback. Iterative 
prototyping using 3D printing was used to rapidly test and refine new concepts (see Figure 
15). The design output was a high-fidelity prototype with additional 3D-printed options for 
several parts. 
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Figure 15: Examples of rapid prototyping used to develop RAIS concepts 
4.5.2.2 Outcomes 
In particular, the feedback from the in-person assessment highlighted two crucial flaws in 
the RAIS system which were overlooked by participants interacting via video-conferencing. 
The first flaw related to usability. The user highlighted that the device did not afford 
sufficient flexibility for positioning and lifting the internal component. The second related to 
the OTT attachment system, because the user disagreed with participants who had advised 
that remote facilities would have an appropriate rail clamp with which to attach the RAIS 
device to their OTT. Through the interdisciplinary workshop and iterative 3D printing, the 
team developed solutions which afforded more flexibility on device positioning and OTT 
attachment. The improved designs are shown as the output of Activity 4 in Figure 10. 
4.5.3 Clinical Verification: Loop 3 
This section refers to the third iteration of the waterfall verification loop (see Figure 8). 
4.5.3.1 Activities 
In the third design verification loop (see Figure 10, Activity 5), design input came from a 
surgeon based in the UK with experience in gasless surgery, or a ‘proxy user’ 100. While others 
have cautioned against verifying designs with users not based in LRHCs, in this case the 
modified aspects required in-person assessment because they had been previously 
overlooked by stakeholders interacting via video conferencing. The proxy user assessed the 
device by performing a simulated laparoscopic procedure using the device on a cadaveric 
model. The design process comprised of engineers and designers refining 3D printed parts 
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to enable manufacture in stainless steel and the design output was a complete high-fidelity 
prototype suitable for travel to remote locations in India and testing with end-users.  
4.5.3.2 Outcomes 
This verification loop did not catalyse design changes. While the proxy user feedback 
suggested the proposed design changes solved issues highlighted in the previous loop, the 
team resolved to get feedback from end-users in LRHCs before further design modification.  
4.5.4 Clinical Validation 
Ethical approval for the cadaveric study at ARSICON 2019 was granted by Martin Luther 
Christian University in Shillong, India (Ref: VI/I(8)/UREC/EA/272/2015-6116) and approved 
by the Faculty of Medicine and Health Research Committee at the University of Leeds in the 
UK (Ref: MREC 19-029). Informed, written consent was obtained from all participants in the 
study.    
A cohort of end-users in LRHCs participated in the RAIS clinical validation (See Figure 10, 
Activity 6). They used the high-fidelity prototype on cadaver models at a surgical workshop 
arranged by the team to take place at a rural surgery conference. Informed, written consent 
was obtained from all validation study participants.  
4.5.4.1 Activities 
First, each participant was briefed on the project and workshop purpose and given an 
instruction sheet (see Appendix A) and an opportunity to ask questions. Participants were 
then shown snapshots of the design progression and watched a video demonstration of how 
to assemble and use RAIS. They then performed two surgical tasks: 1) assembling the RAIS 
prototype and 2) using it to perform a simulated diagnostic laparoscopy on a cadaver model. 
Next, they were interviewed. During this recorded, semi-structured session, participants 
filled out National Aeronautics and Space Administration Task Load Index (NASA TLX) for 
both surgical tasks and answered a questionnaire on the feasibility of using RAIS in the LRHC 
they worked in.  
The NASA TLX was selected to evaluate the usability and suitability of the device developed 
for its end-users. It has been used extensively in medical device development 145 and 
accounts for the additional dimensions of frustration and performance when compared to 
other workload analysis techniques 146. The questionnaire comprised nine statements, each 
followed by a seven-point Likert Scale, which ranged from “Strongly Disagree” to “Strongly 
Agree”. Each statement enquired whether a commonly-cited challenge of using medical 
equipment in LRHCs (see 2.1.3) had been successfully mitigated by the RAIS design. The 
   - 52 - 
questionnaire concluded with open questions for participants to share further barriers to 
using RAIS in LRHCs and any ideas, comments or relevant information. For the full 
questionnaire and TLX, see Appendix A. The investigation purpose was gain feedback on an 
initial prototype from users to move forward with and improve the design, not establish 
definitively whether the device met requirements, and therefore no formal statistical 
analysis was performed on the results. 
4.5.4.2 Outcomes 
Most validation study participants (total n=13) were general surgeons with previous 
experience of performing gasless laparoscopy in rural or low-resource settings (n=9). Other 
participants (n=4) included a General Practitioner, a Registered Nurse and two surgeons 
without prior experience in gasless laparoscopy.   
The NASA TLX results indicated the device was easy to learn and use. For both workshop 
tasks using the RAIS device, participants reported low averages on all of the six NASA TLX 
subscales, indicating a low overall user workload in performing each surgical task on the 
cadavers, and a high user performance. For device assembly, the unweighted average was 
5.5 (0.9, 10.1) on a scale of 1 to 21 and for device use to perform an AWL, 6.0 (1.2, 10.8). The 
95% confidence intervals for the mean are large, which is expected due to the small sample 
size. However, the confidence interval upper extremes still lie below the workload scale 
midpoint, demonstrating RAIS’ usability. The outliers shown in Figure 6, which indicate high 
workload, were correlated to participants with no experience performing gasless 
laparoscopy, which requires formal training 140.  
The questionnaire results, summarized in Figure 16, strongly suggest the team produced a 
surgical device appropriate for a LRHC using the selected methods. Participants who 
disagreed with the first statement ‘I have experience working in a rural or low-resource 
hospital’ (n=1) were discounted from the results analysis. On average, participants gave the 
device normalized scores of 90.5/100 (86.1, 94.9) over eight statements. In question 5, 
participants rated their disagreement/agreement with the statement: ‘A rural or low-
resource hospital could repair this device’. This was the most controversial questionnaire 
statement, with the lowest average and most variable participant scores. When probed on 
answers, three of the four participants who were unsure or disagreed with the statement 
explained they could seek advice from local mechanics who could perhaps perform basic 
repairs, but ultimately there were no mechanics, engineers or manufacturers in their 
proximity that had experience with medical devices. User would feel uncomfortable trusting 
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local mechanics with a surgical device they could not easily replace. Hence, the 
questionnaire also revealed that one requirement set in Phase 2 was inappropriate.  
 
Figure 16: User Testing Results: a) Usability Study b) Rural Facility Suitability Questionnaire  
It was recognised that several forms of response bias could have affected the usability and 
questionnaire results. It is widely acknowledged during product testing that informants 
often tell designers what they think they want to hear, a form of social desirability response 
bias 147. This effect can be augmented by the presence of a foreign interviewer or an 
interviewer with a perceived as having a higher social status than the interviewee 148. To 
mitigate the bias the team selected a member of the design team considered less-qualified 
(Postgraduate, 1yr experience) than most study participants (mostly practicing surgeons, 
8+yrs experience) to perform the interviews. To further mitigate this effect, during the 
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briefing, cadaveric workshop and interviews investigators communicated that the purpose 
of the study was to identify flaws in RAIS and ways to improve the design and encouraged 
participants to answer honestly and discuss their criticisms of their design. Despite these 
efforts, there is likely to be remaining bias causing participants to over-score RAIS.  
Nonetheless, throughout the interviews and in response to the questionnaire’s open 
questions, participants also communicated ideas for improving RAIS and highlighted 
potential flaws. All statements of this nature were recorded, and distilled into a list by the 
author. Similar statements were grouped and the frequency aspects were mentioned was 
recorded. Design actions were developed from this feedback (Figure 17). New contextual 
insights were discovered too, such as difficulties communicating effectively during surgery 
with nurses and assistants, who sometimes had no formal training and spoke different 
languages. New flaws identified included aspects such as the potential to compromise 
sterility by tearing gloves on the device moving parts. Therefore the activities helped identify 
potential improvements to increase value for users without incurring additional expense. 
 
Figure 17: A summary of design changes and actions generated as a result of end-user 
feedback on RAIS Prototype 1 
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4.5.5 Phase Outcomes 
In the ‘Act’ phase of the design process, the team developed a new concept to meet the 
clinical, contextual and user requirements for an AWL device for gasless laparoscopy in 
LRHCs. The outcomes were a high-fidelity prototype which was well-received by users, as 
well as a set of ideas for small improvements to the design.  
4.5.6 Phase Evaluation 
4.5.6.1 Design for Safe Surgery Roadmap 
The iterative local end-user involvement and focus on resourcefulness and creativity rather 
than technical sophistication advocated by the roadmap 31 helped designers avoid potential 
pitfalls and develop a FI. Every verification or validation stage, even with the same end-users, 
resulted in ideas for design improvement, exemplifying the need for iteration. However, the 
roadmap provided little advice on methods for verification and validation. The team found 
interaction via video conferencing led to design over-simplification, since stakeholders could 
not pick up on usability aspects. An improved roadmap could highlight the benefits and 
drawbacks of using both virtual and in-person methods, and emphasize the need for both. 
The roadmap also suggested forming collaborations with local universities in this phase 31. 
Indeed, stakeholders based at universities provided most of the iterative feedback. With 
experience in gasless laparoscopy and reliable access to video conferencing, they provided 
frequent valuable feedback. However, not being based in remote facilities, they overlooked 
some aspects related to those settings. Therefore ensuring end-users in remote facilities 
also had the opportunity to assess the RAIS design was important to supplement their 
contributions.   
Finally, the roadmap did not provide sufficient advice on validating devices for LRHCs. On 
reflection, the validation event yielded a rich translation of quantitative and qualitative 
design information from end-users to designers. The workshop and study design were 
considered integral to this success. The initial briefing of participants to give them an 
overview of the process so far helped participants to understand the objectives of the 
project and stimulated critical thinking early on, with surgeons asking questions and offering 
opinions before even using the prototype. The open hands on evaluation in pairs gave 
surgeons an opportunity to thoroughly inspect the prototype and test it to their own 
specification, whilst also helping them to obtain an understanding of any potential 
difficulties for an operating theatre assistant through role play. Finally, the individual semi-
structured interviews gave surgeons the opportunity to give both qualitative and 
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quantitative feedback, whilst the author was able to obtain a comprehensive understanding 
of their answers by prompting participants to discuss their scores. The timing of this 
milestone, which was planned within the first 5 months of the project commencing, enabled 
the design team to make changes to the device design based on the information gathered 
relatively easily, whilst in a stage prior to manufacturer involvement or regulatory 
submission. Consideration of bias in such studies is also vital 147,148, and not highlighted by 
the roadmap 31. 
4.5.6.2 PD 
Reviewing studies involving users in designing devices for LRHCs revealed most thought it 
best to prioritise involving them in early design phases. In the first verification loop, the 
design team focused purely on achieving the priorities and requirements set out by the 
participating local stakeholder, rather than considering technical feasibility, so they had 
almost complete control over the design direction. Technical aspects such as manufacturing 
feasibility and strength were prioritised afterwards, once the desired functionality had been 
achieved. Therefore later verification loops did require less user input. However, the 
validation stage revealed that user input could still add significantly to the design process, 
and that to get useful feedback, ensuring stakeholders feel comfortable criticising the design 
is an important consideration. Therefore the design team again found their sustained 
approach to PD yielded significant rewards. As with previous phases, the importance of 
consulting a variety of stakeholders was evident. 
4.5.6.3 Frugal Innovation 
Within each design verification loop, focus on the FI criteria helped guide the design process 
and select concepts, since there were many solutions for achieving requirements. Instead of 
aiming to impress users from the beginning, typically the team would first present the 
simplest, low-cost solutions, and then refine them based on iterative feedback from 
participants. Having users invested in the project enabled this, as they did not lose 
confidence when low-tech designs were presented to them 100, providing the design team 
with the opportunity optimise performance. This iterative participant feedback was crucial 
in developing the frugality of the device. Even in the final validation stage, end-users came 
up with further frugal ideas and ways to increase value for them without affecting the design 
cost or complexity. 
Optimising the device performance also required use of sophisticated optimisation 
methods. For example, the design team relied heavily on use of FEA to optimise the device 
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for requirements such as lightweight and low cost, while maintaining robustness and 
appropriate safety factors. 
4.6 Phase 4: Design to Manufacture 
 
4.6.1 Phase Activities 
In this phase, the team planned to identify an appropriate in-country manufacturing partner 
and produce a final RAIS device suitable for testing in human clinical trials. Together with 
participating local stakeholders, the team established criteria to select a manufacturing 
partner. In addition to capabilities in manufacturing and undergoing regulatory approval of 
new medical devices, willingness to participate in bi-directional discussions to refine the 
design for low-cost manufacture and produce iterative prototypes, similarly to clinical 
stakeholders, was desired. Understanding of the needs of LRHCs and an ability to supply 
product aftercare or spare parts to them was also necessary. Several manufacturers meeting 
these criteria were contacted, and site visits were arranged by members of the team in the 
product design industry to select a partner. During these visits, the team presented an 
overview of the device, highlighting key areas of manufacturing complexity, and provided 
several physical parts for the manufacturer to assess. 
Due to the COVID-19 pandemic, all further activities involving stakeholders in India were 
conducted via video conferencing. Therefore the design to manufacture process comprised 
of bi-weekly online meetings between the design team and manufacturers, each focused on 
one aspect of the design. Local stakeholders participated to explain concepts and assess 
initial prototypes. The phase culminated with a live, online cadaveric demonstration of the 
first prototype to local clinical stakeholders, who provided feedback via a survey. 
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4.6.2 Phase Outcomes 
The team met with three potential manufacturers to discuss developing the RAIS device. 
After these discussions, which involved and in-depth discussion of the project aims and 
expectations, all three manufacturers expressed an interest. However, one manufacturer 
stood out due to their obvious enthusiasm and understanding of the aims of the project, as 
well as personal experience of remote healthcare centres. 
Following the bi-weekly meeting process, the manufacturer made several improvements to 
the device for users. For example, being aware of difficulties transporting and storing 
equipment, they developed a transport case that contained laser-marked positions for each 
component, to help users with assembly and disassembly and prevent them from losing 
parts (Activity 7, Figure 10). Understanding the focus on low cost but high quality, they 
worked closely with the design team and clinical stakeholders to make improvements in part 
strength, reduce manufacturing complexity and achieve clinical requirements. For example, 
through several design iterations, they designed manufacture of the lift assembly as one 
component (Activity 8, Figure 10), while retaining all the features required by clinical 
stakeholders. These innovations enabled the team to achieve the cost goals set out at the 
beginning of the project. 
Through the online, interactive cadaveric evaluation session, involving the design team, 
manufacturers and clinical participants, stakeholders were able to identify enduring flaws in 
the prototype and suggest improvements. Participant survey feedback was positive, 
however they emphasized that without using the device in person, they could not be sure it 
was adequate, so the results had limited use. 
4.6.2 Phase Evaluation 
4.6.2.1 Participatory design 
In identifying and selecting a manufacturing partner, participants and product design 
industry partners were indispensable, providing experience in industry and the local context. 
The sustained approach to involving local stakeholders meant in this phase participants 
could help optimise prototypes by testing them and highlighting when small modifications 
made for manufacture affected device performance or function significantly. They explained 
and demonstrated to manufacturers why complex manufacturing features were necessary 
and facilitated achieving the best compromises between manufacturing complexity and 
functionality. The online cadaveric evaluation showed that participants can provide useful 
contributions via video conferencing, but also reiterated the findings of phase 3, showing it 
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cannot substitute interacting with the device in a real clinical environment. Clinical 
stakeholders expressed this using the feedback survey. 
4.6.2.2 Frugal Innovation 
Working with a manufacturer with understanding of LRHCs helped further optimise the RAIS’ 
value for users, who expressed great satisfaction with the manufacturer’s custom case for 
storing and transporting the device (Activity 7, Figure 10). 
4.7 Summary  
This chapter investigated Objectives 3 and 4 of the thesis. By providing a detailed account 
and tangible examples of implementing the integrated approach developed in Chapter 3, 
the work here addresses the paucity of evidence relating to use of these approaches in 
designing technologies for global surgery. The systematic evaluation of work completed and 
the progression of the RAIS device design in each phase shows how each was influenced by 
the Design for Safe Surgery Roadmap and the principles of FI and PD.   
The major limitation of the work in this chapter is that it only reflects on the effect of the 
approaches on the technology designed. While, as discussed, this was the primary aim of 
the project, it has also been argued that when using a PD approach, especially one which 
aimed to involve participants as more than just informants on the design context, the effect 
of this approach on the participants must also be evaluated 92,102. 
Therefore, prior to discussing the overall suitability of and suggestions for improving the 
design approaches investigated, which relates to Objective 6 and is addressed in Chapter 6, 
the next chapter presents the results of a study investigating how clinical stakeholders 
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Chapter 5 
Evaluation of User Gains from the Design Approach 
Chapter 5 considers the effect of the design approach on the clinical stakeholders involved, 
to complement Chapter 4 which evaluated how it affected the RAIS design. An exploratory 
qualitative study, comprising of five semi-structured interviews with clinical stakeholders 
who participated in the design of RAIS, is described. The study investigates what clinical 
stakeholders gained from being involved and what affected these gains in terms of 
facilitating or impeding them. Evaluating these ‘Indirect, Unintended’ impacts in addition to 
the intentional impact (on the RAIS design) provides a more holistic insight into the potential 
benefits of involving users in designing technologies for global surgery. 
5.1  Introduction 
As discussed in 2.4.2.3, the Objective of using PD to design technologies for LRHCs is most 
commonly to improve or reduce the cost of the technology 104. Indeed, this was the Objective 
of using a PD approach to design RAIS, and Chapter 4 highlighted its significant influence on 
the design development. However in wider PD literature, while prototypes, products or 
design concepts are still the most frequently evaluated Impact of PD projects 92,104, some 
projects prioritise gains for the participants, such as their psychological empowerment or 
up-skilling 105,149.  
Several studies have argued that PD practitioners developing global medical technologies 
should prioritise participant gains 58,69,102, adapting their Objectives and overall approach to 
focus on mutual learning and developing local innovation capacities in LRHCs 88. Yet PD 
participants are also likely to be surgical technology users in LRHCs, who are often in short 
supply, so it could be argued that use of their time should be minimised. PD can also be 
resource-intensive for organisations 92. To justify using PD, it is important to be able to 
consider all the benefits of using it and be able to maximise outcomes. Critically lacking in 
literature is evidence of how participants benefit from PD approaches in this context and 
how these gains can be impelled. To lay the foundations for addressing the paucity of 
evidence in this area, an exploratory qualitative study was performed. The study aimed to 
answer two research questions: 
1. What did clinical stakeholders gain from being involved in designing RAIS? 
2. What affected these gains, in terms of facilitating or impeding them? 
To investigate these research questions, 5 clinical stakeholders who participated in designing 
RAIS were interviewed. The results are intended to initiate and inform future studies by 
increasing understanding of concepts related to the Impacts of PD in this context 104. 
Evidence from this and further studies could be used by organisations to achieve more 
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impact in increasing global access to surgery when using a PD approach to designing global 
surgical technologies.  
5.2  Method 
Exploratory studies often warrant using a qualitative approach, and in particular, semi-
structured interviews. This method allows the researcher to explore thoughts, beliefs and 
feelings of participants, and delve more deeply into personal topics and reflection by asking 
follow-up questions to seek detail or clarification. They are especially useful for identifying 
new phenomena 150 and are commonly used to evaluate the outcomes of PD projects for 
participants 92,98,103 which can be hard to measure 103. Hence they are particularly 
appropriate for exploratory research into the ‘Unintended or Indirect Changes’ attribute of 
the Impact of a PD approach 104,151. 
5.2.1 Recruitment and Consent 
Ethical approval for this study was granted by the Faculty of Engineering and Physical 
Sciences Research Ethics Committee at the University of Leeds in the UK (Ref: MEEC 20-023). 
Informed, written consent was obtained from all participants in the study.    
A sample of six clinical participants involved in the RAIS design process were purposively 
recruited for the study 152. The participants selected were those involved in the project most 
frequently, and hence likely to have experienced impacts from being involved. The selection 
process also included an aspect of maximum variation sampling: to the best of the author’s 
knowledge, the sample contained participants who had different experiences of the process 
and were likely to provide different insights. They had different clinical roles and varying 
levels of previous experience designing technologies. 
Participants were recruited via email and provided with an information sheet (Appendix B). 
No participants declined to be interviewed, but the final interview did not take place as the 
author concluded that data saturation had been reached. An overview of the participants 
interviewed is provided in Table 1. All participants have been given pseudonyms to protect 
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Arpit 1-4, 6-10 Low 30:44 
Bahar 1-4, 6-10 Low 37:35 
Chaman 1, 5, 7, 8, 10 High 42:28 
Danvir 1, 7 High 39:59 
Ebrahim 1-10 Low 38:46 
 
5.2.1 Data Collection 
Participants were interviewed by the author. Since she had worked closely with participants, 
it was recognised that they might more likely to withhold criticisms or exaggerate gains 
during interviews. However, the professional relationship between the author and 
participants had been built around participants evaluating designs and concepts the author 
had developed, and it was felt that a trust had been developed where participants knew 
they could be critical and were actively encouraged to be so. Since her participation in the 
project was imminently ending and participants were aware that the author was junior to 
them in both age and profession, they had less reason to withhold frustrations. Furthermore, 
the author’s in-depth knowledge and experience of the design process was considered an 
advantage in that it could allow her to pick up on subtle aspects. To reduce the potentially 
biasing effect of the author’s previous experience and knowledge of the interviewees and 
design process on the collection of results, the author performed extensive research into 
interviewing techniques and reviewed the interview topic guide (Appendix C) and example 
questions with an experienced qualitative researcher in PD projects, with no prior 
involvement in the RAIS project.  
Others have reflected that the timing of interviews affects the data collected, the advantage 
of ‘sooner’ being that participants remember events more clearly, and ‘later’ being that 
longer-term gains can be assessed 153. However, longer-term gains are often difficult to 
unequivocally attribute to the PD approach since unrelated factors are likely to influence the 
participant’s perspective over a number of years 153. Therefore, the interviews were 
conducted at the end of Phase 4, 1 year and 9 months after the project commenced, whilst 
participants memories were likely to be clear. 
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Interviews were arranged at the convenience of participants and conducted using video-
conferencing, which is considered equivalent or even superior to other interviewing 
methods 154. Participants were interviewed individually, since it was felt this would make 
them more comfortable discussing personal feelings, and each was recorded with verbal and 
written permission. The topic guide (Appendix C) was based on an existing study with similar 
aims 105,153 and adapted to be more appropriate for this study’s aims and participants 
through an iterative process including two pilot interviews with a non-clinical RAIS team 
member and another colleague. Each interview began with a discussion of the interview 
purpose, emphasizing that the focus was to examine how being involved had affected them 
personally. Once the interviewer felt the participants understood this aspect, she asked 
several ‘warm-up’ questions focused on the aspects below considered likely to affect their 
personal gains, to put participants at ease and add context to their responses.  
1. Current role 
2. Previous experience designing technology 
Then, the following topic areas were discussed.  
1. Motivations for participating  
2. Feelings about personal contribution to and influence on the project   
3. New knowledge and skills acquired  
4. New possibilities emerged   
5. New outlook on healthcare technology or own practice  
6. Personal gains from participating in the project  
7. Overall assessment of participation in the project  
During the interviews, participants were encouraged to speak about anything else they felt 
was relevant. Specific questions were adapted throughout the interviews based on the 
responses of participants.  
5.2.3 Data Analysis  
Extensive reading informed the process employed to thematically analyse the data 155–157. 
Interviews were transcribed by the author, helping to familiarise her with the data and form 
initial ideas of what might be relevant to the research question. Then the transcripts were 
reviewed to replace content which could be used to identify participants with pseudonyms. 
The transcripts were then analysed separately by the author and an additional coder, who, 
in contrast to the author’s engineering background, had a clinical background and no prior 
experience of the RAIS project or participants. The complete analysis process is shown in 
Figure 18. 
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Figure 18: Thematic analysis process employed on the interview transcripts 
 
The coding process was primarily inductive 158. The transcripts were searched in terms of 
gains, frustrations, impediments and facilitators, to answer the pre-determined research 
questions in 5.1. Each coder reviewed transcripts independently and selected quotes 
relevant to the aims of the study. Each quote was assigned one or more evaluation codes, 
which were iteratively refined during the coding process. Code frequency was recorded. The 
coders individually reviewed their codes and organised them into categories. At this stage, 
the coders met to compare their categories, discussing their content and what each 
contributed in knowledge towards the research question. Through this discussion, the 
coders refined the 25 categories into 3 overarching themes with coherence, clear 
boundaries and enough meaningful data to support each conclusion, evidenced using code 
frequencies.  
5.3 Results 
Through the analysis process, 3 themes were developed: 
 Motivations and Expectations 
 Ways of Working, Collaborating and Communicating 
 Acquiring Skills, Diversifying Careers and Expanding Networks 
‘Motivations and Expectations’, explores the relationship between why clinical stakeholders 
became involved in designing RAIS, what they expected to gain from it for themselves and 
how that may have affected what they did gain. The second, ‘Ways of Working, Collaborating 














































Transcripts Quotes Codes Categories Themes
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and Communicating’ discusses how working within the RAIS team influenced the way 
participants approach their work, particularly with others, and how the approach taken to 
involving and communicating with participants may have influenced that. The final theme 
‘Acquiring Skills, Diversifying Careers and Expanding Networks’ focuses on changes and new 
opportunities described by participants affecting their skills and careers, and what aspects 
of designing RAIS catalysed these. 
5.3.1 Motivations and Expectations 
Unanimously, participants considered helping others a significant personal goal, and 
altruism as their primary motivation for being involved in designing RAIS. The prospect of 
creating benefit for others drew them to the project, rather than an opportunity to further 
their own fortunes, particularly since it focused on addressing the needs of those they 
considered less fortunate than themselves.  
“this whole idea of being part of a collaborative project, where the ideas 
and vision is driven by those who are going to use it was very 
appealing” - Ebrahim 
“daily wage workers… why not give them the advantage of minimal 
access surgery through the gasless device” - Bahar 
“the purpose to join this technology development of a device was to 
increase its accessibility… so more people can use it... we are looking for 
the developing countries... many areas in Africa.... Southeast Asia...” - 
Chaman 
Of course, actions are rarely entirely selfless, and most participants expressed a sense of 
purpose, satisfaction and enjoyment gained through working on the project to help others. 
Arpit, Bahar and Ebrahim, who were involved in all design stages (Table 1), reflected that 
since this aim was shared by everyone, it also helped to unite team members from different 
professions and cultures. Chaman and Danvir, who had previous design experience, noted 
that this did not always happen, and that conflicts in objectives between themselves, whose 
priority was to provide the best solution for patients and surgeons, and engineers or 
manufacturers, whom they perceived as primarily wanting to make money, could make 
collaboration difficult.  
“you know, you have a keen interest in doing surgery and finding 
solutions so you're seeing every day that okay, we are taking one step 
or multiple steps in a day, sometimes, towards that. That's a very 
fulfilling kind of feeling.” - Arpit 
 “everybody was just on the same level… focused… making sure we get 
this project done and come up with this new device”  - Ebrahim 
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“their motive is primarily making money... they said 30% of the money 
comes from disposables... but we insisted that, see we are doing it for a 
resource-poor setting... there is no point in adding something 
unnecessarily disposable... it may not have a huge market, but still, it 
will serve the purpose...”  - Chaman 
Hence, a focus on user needs facilitated the forging of strong partnerships and associated 
benefits which are discussed further in the following two themes. On the other hand, 
perhaps this focus was so unmitigated that participants did not consider how they could 
benefit from being involved. Certainly, participants found it difficult to talk about personal 
gains. At the start of the interviews, when answering a question about the impact of some 
aspect on themselves, they would frequently drift back to discussing how that aspect 
affected RAIS instead, despite repeated emphasis that the interview was about how the 
process affected them personally. Ebrahim felt that considering personal gains might have 
even negatively impacted the project. 
“I didn't get involved in this project, first of all, for personal gains, you 
know… one of the biggest barriers is when your personal gains come in 
the way… your personal biases come in….”  - Ebrahim 
Interestingly, since participant motivations and expectations revolved primarily around 
helping others, so did most frustrations discussed by participants. Participants expressed 
dissatisfaction when their expectations of helping others were not met, for instance when 
they felt progress was too slow or the project hadn’t yet had the impact they hoped. Some 
frustration with timescales was expressed by three of the five participants. Danvir 
highlighted that perhaps this frustration occurred when it was felt that team members based 
in HICs did not understand how pressing the need for the technology was, or feel enough 
urgency to implement it.  
“I was expecting by this time there will be at least 10-12 centres in 
India… we’re not there yet” - Arpit 
5.3.2 Ways of Working, Collaborating and Communicating  
Despite limited motivation to further their personal interests, participants became more 
introspective further into the interviews, and began to articulate more personal gains. 
“my purpose of getting involved was to, for... patients who are in the 
global south to benefit, for the collaborators to benefit, but eventually 
some of the other benefits has come to me as well and I wouldn't deny 
that” - Ebrahim 
In particular, the three participants involved in the most design activities and decision-
making, Arpit, Bahar and Ebrahim (Table 1), described how working on the project 
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heightened their awareness and appreciation of the benefits of multidisciplinary 
collaboration. They developed interpersonal skills for teamwork, such as recognising the 
benefit of listening to and considering the ideas and perspectives of others and the value of 
their own contributions and role in the team. 
“I think whenever you are starting working in a team with different skill 
sets and different, you know, viewpoints, one thing it teaches you is that 
you have to listen to others viewpoint and sometimes they are so much 
you know more learned… now I listen to others, and you know, try to 
have their version, their viewpoint on everything, so I think, I think that 
makes me a better team person” - Arpit 
 “Teamwork... brilliant, I think I have been repeating this again and 
again, but that is the most important thing which I have learnt” - Bahar 
Arpit, Bahar and Ebrahim also described how they planned to or had already begun to use 
this interpersonal learning and newfound enthusiasm for collaboration to pass on their 
knowledge to others, and create changes to their workplaces and the way they approached 
solving problems. 
“engineer people let's say they're working in health domain, they will do 
finding solutions on their own, without having any understanding about 
health, and the health people also will be finding the solution to the 
same problem with no contact with design and interviewing people. 
And now it shows me that, how stupid is that” - Arpit 
“the way we have approached this designing process…I'm going to use 
it for future works… using that same experience of working with a group 
of collaborators who come with different backgrounds” - Ebrahim  
Chaman and Danvir highlighted the value of these skills by describing the inherent conflicts 
they had previously experienced between the priorities of engineering and clinical 
stakeholders in a team, and the importance of understanding one another’s perspective to 
resolve these and make the right compromises. 
 “We need to sort of come with a compromise, okay, so, we accept the 
sort of thing. So there is a lot of disconnect between the clinicians and 
the designers… learning has to be both ways, so the engineers need to 
learn what the actual need of the clinicians are, the clinicians also need 
to learn what is possible or not possible” - Chaman 
However, whilst there were learning opportunities from working in this multidisciplinary 
team, these differences in professional and cultural backgrounds were a potential source of 
conflict. Clinical stakeholders described frustrations which centred on idiosyncrasies in 
paperwork and regulation between countries, with different ways of planning work and with 
the pace of work.  
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“in India, the pushy kind of system works better. It will be, okay, from 
tomorrow we have to do it, very tomorrow we have to do it. Whereas, 
right, there [in the UK] it's like okay, the timeline is next week or next 
next week or this month” - Arpit 
 “when you're doing it [designing medical devices] with the team like a 
big University then you need to go by the standard protocols and all 
those things… nothing much is happening for quite a long time” - 
Chaman 
In particular, most participants based in India felt that their need to test prototypes in person 
in a clinical setting to provide accurate feedback was not fully understood or provided for by 
other stakeholders in the team, causing some frustration. Arpit and Chaman went on to 
highlight that they felt this lack of opportunity to test prototypes in person, which they 
attributed in part to the team being based across two continents, had limited the 
contributions they could make, and as a result Chaman was anxious about the quality of the 
final device. They felt their contributions were less valuable online and that limited their 
ability to be a part of the team. 
“Had it been in, let’s say the same country, we could have, I think, done 
much better” - Arpit 
 “that's one problem we have with any of the company, they don't like 
us, keeping on changing the design or altering it because it makes it 
difficult for them, especially if they're considering producing in bulk and 
so on. But then before that actually when saying the final word, it's 
without using in different types of patients. It's again difficult to say 
that well okay this is the final and we don't want to make any more 
changes” - Chaman 
Influences on the way they worked and collaborated were only discussed by Arpit, Bahar 
and Ebrahim, who were involved in all design stages and decisions making and also had little 
previous experience in design (Table 1). These participants reflected on how regular 
communication from the design team to keep them up to date, having iterative 
opportunities to provide feedback and being involved in decision making and planning were 
factors that enhanced their experience of multidisciplinary collaboration. 
“I have seen some teams failing because of this thing, either timelines 
are too short, so timeline is decided by one person or one portion of 
people, whereas others might, are not able to follow that” - Arpit 
“you are also giving us the feedback at every level. Now I will label it 
as... as a formative assessment... involving us… at every point, 
whenever you're raising some points or taking our feedback” - Bahar 
Being involved in this way helped not only reduce frustrations centred around their influence 
on the device, but made them feel valued and recognise that their contributions were 
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important, even if their ideas did not materialise in the final product. In particular, 
participants reflected on the role of good leadership and an ethos of equal stakeholder-ship 
recognised and practised by all team members, in improving their confidence and perceived 
performance throughout the project. 
“if, let's say, they [my contributions] were rejected, they were rejected 
with a valid reason… til the point where I also said yes, it makes sense.” 
- Arpit 
“I had that, that unique advantage… I was able to raise pertinent 
questions… that helped the engineering team and the design team” - 
Bahar 
 “being valued was very important for every team member so, so I think 
because of that everybody felt that I, I can contribute more, over and 
above what I would have contributed because I'm being valued for who 
I am, not, irrespective of my background or my professional 
achievements of whatever you know, big or small.”  
 “the dynamics between the group was very useful because everybody 
ensured that everyone felt that they were part of the team” 
 - Ebrahim 
5.3.3 Acquiring Skills, Diversifying Careers and Expanding Networks 
As well as interpersonal skills, four of the five participants learnt new technical skills. They 
described increased knowledge of engineering and design considerations, some of which 
they felt were useful in their current roles, such as knowing different types of materials 
which could withstand autoclaving. Through observing the team evaluating different designs 
with users, they gained an appreciation of the importance of fine detail and investigating 
norms in design. Arpit, Bahar and Ebrahim described developing a more critical mind-set 
surrounding healthcare technologies, and becoming more aware of opportunities for 
innovation and ways to improve their practice. They also gained awareness of the wider 
context of healthcare technology design, becoming more interested in aspects such as 
manufacturing, implementing and diffusing technology in LRHCs.  
“I think it has helped me to push my innovative ideas that I would have 
otherwise not used... I felt that I could do this... come up with ideas... 
I've never engaged in the sort of activity before... because everything is 
just sort of given to you, that this is what are you going to do” - 
Ebrahim 
Danvir and Arpit also revealed they had existing career aspirations or personal interests in 
biomedical technology, which they were able to explore further through being involved in 
the project. For both, utilising links with team members and the wider global health 
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community led to career developments. For example, as a part of the project, one 
participant was able to complete a course in biomedical engineering designed specifically 
for LRHCs. Other participants made new links through the project with members of the 
international community interested in gasless surgery and RAIS, facilitating new 
collaborations and research opportunities, although it should be noted that some of these 
opportunities were also likely to be linked to their involvement in other projects with the 
GHRG-ST, rather than specifically designing RAIS.   
“it’s... kind of a dream that one day we will work with such a team and 
we've designed something, and have something of our own, and when 
we saw this happening with RAIS and this team, I think there was no, no 
way I could have said no to this” - Arpit 
Using the skills and knowledge obtained through designing RAIS, some participants even 
began to initiate their own innovation projects. Through these, and through disseminating 
their experience designing RAIS at events and conferences, participants shared their 
knowledge of designing for LRHCs to a much wider community. 
 “I got a glimpse into the world of designing and thanks to your team 
that we have started evolving, looking for more... low cost innovations 
and solutions...things which can we can start at our Institute and pass 
on across... colleagues… peers… other medical colleges…” - Bahar 
Again, these gains had links to the way participants were involved, with opportunity to skill-
share with, observe and be immersed in the practice of designers and engineers being 
crucial. Participants also reflected that maintaining an open mind-set and building 
meaningful, supportive relationships with other team members enhanced these learning 
and skill-sharing opportunities. 
“one thing I have learned with this thing that whenever you sit with the 
new people with new or different kind of skill sets the learning curve 
certainly takes a upward, you know, rise” - Arpit 
 “The development of you know, very easy rapport… every person was 
very much approachable” - Bahar 
5.4 Discussion 
The purpose of this study was to explore whether clinical stakeholders made personal gains 
from being involved in designing RAIS, and what facilitated or impeded those gains.  
Despite approaching the thematic analysis of the transcripts from very different 
backgrounds, with one coder having no prior experience of the project or stakeholders 
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involved, the two coders identified extremely similar codes and categories. The iterative 
process of refining these into three themes was straightforward and both felt satisfied that 
their categories and codes could be described fully within these. 
The first theme, ‘Motivations and Expectations’ explored the significance of motivations and 
expectations in influencing participant gains. The responses of participants indicated that a 
shared goal and focus on user needs was important for experiencing gains from achieving 
personal goals, forging strong links between the team and for the motivation and enjoyment 
of clinical stakeholders. However, these motivations were central to frustrations 
experienced by clinical stakeholders too. Interestingly, as well as not having considered gains 
for themselves, when asked about disadvantages to themselves from participating, 
participants also had very little to say. Perhaps as well as personal gains, they consider 
personal drawbacks to themselves as less important than this goal of helping others. It was 
recognised throughout the project that participants gave their time generously, and it seems 
natural that if they felt they were making personal sacrifices for the project, then delays or 
barriers to them achieving their goal of helping others might cause frustration. In addition 
to this, participants frequently expressed not expecting or desiring to gain for themselves. 
This raises the questions as to whether there is indeed any benefit, for clinical stakeholders, 
resulting from being involved through different stages of the project, or whether it is more 
likely to result in them making personal sacrifices.  
However, the second theme, ‘Ways of Working, Collaborating and Communicating’ 
highlighted opportunities for clinical stakeholders to learn new ways of working and 
collaborating arising from working closely with others in an interdisciplinary, multinational 
team. This environment catalysed interpersonal skill development for some participants, 
who had already begun to implement and use what they learnt to make changes to their 
day-to-day roles. Participants who did feel that they had gained in this area reflected that 
these gains were linked to the way they were involved. The project emphasis on frequent 
and sustained communication, a non-hierarchical team structure and ensuring everyone 
was recognised for their contributions in outputs were praised. Indeed, participants that 
were not involved in this way and purely provided feedback on prototypes expressed more 
dissatisfaction with outcomes and didn’t describe any interpersonal skill development. 
Rather than gains, they described frustrations regarding difficulties collaborating across two 
continents and several disciplines. In fact, all participants that were geographically separated 
from the design team agreed they needed further opportunities to evaluate prototypes in 
   - 72 - 
person to feel that their contributions were worthwhile and accurate, highlighting a key 
barrier to PD frequently mentioned by practitioners in this context 100. 
The final theme, ‘Acquiring Skills, Diversifying Careers and Expanding Networks’ highlighted 
how using innovation skills and knowledge developed through working closely and skill-
sharing with engineers and designers on RAIS, participants were able to make useful gains 
towards achieving their career ambitions, creating and even leading new innovation projects 
in global health. Networking facilitated by the project led to new collaborations and 
opportunities too. The gains described in this section were primarily driven by the 
stakeholders themselves rather than being intentional outcomes of the project, but again, 
involvement in the project provided a useful environment with opportunities that 
stakeholders were able to use to their personal advantage. Notably, all participants were 
passionate about directing gains they made to further their impact on improving global 
surgical care and all were enthused at the prospect of, or already developing, more low-cost, 
robust surgical technologies. Gains described in this theme were particularly useful for 
participants based at Universities, who gained skills, knowledge and networks to diversify 
their careers and initiate their own global innovation projects. Others have advocated for 
the forming of collaborations between universities, manufacturers and other stakeholders, 
similarly to the RAIS project, since they can provide an excellent environment for in-country 
for innovation 31,108,110.  
Overall, participants described several ‘Unintended or Indirect’ Impacts from being involved 
in designing RAIS from which they benefitted, mostly arising from the opportunity to work 
and skill-share within an international, multidisciplinary team. However working across large 
physical distances, slow timescales and perceived lack of influence on the design could lead 
to frustration rather than gains for participants. Furthermore, all the gains described by 
participants can only be indirectly attributed to being involved in the project, since they were 
primarily driven and achieved by the participants themselves and were not intentional 
outcomes of their involvement. However, in general there was a marked difference between 
the gains and frustrations described by participants involved in all design stages, and those 
involved purely in evaluation stages (Table 1). The design team’s efforts to communicate, 
co-create and commend contributions were considered important by participants involved 
in all stages to the gains they experienced, as well as having opportunities to iteratively test 
prototypes in person.  
The study does not provide a representative view of all participants involved in the RAIS 
project, and since the findings are based on a single data collection method, they cannot be 
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used to confirm any hypothesis. Of course, there is also likely to be a level of subjectivity to 
the results, but it is a unique study in the fact that it does investigate the perspectives of 
clinical stakeholders on this subject. The outcomes indicate that gains for clinical 
stakeholders may be worth investigating further, especially since some of the gains clinical 
stakeholders made while designing RAIS could help them to create long-term impacts by 
developing their own local surgical technology innovation capabilities. Focusing on 
developing innovation capabilities within LMICs themselves may help to overcome some of 
the most difficult aspects of designing in this context, such as working across large physical 
distances and gaining an understanding of unfamiliar contexts. Ensuring clinical stakeholders 
make relevant gains may also help to reduce their frustration with outcomes, as typically, 
medical device design is risky and projects often span many years 51. Their continued support 
can be vital in disseminating new technologies 22,58 and may help scale-up and implement 
them. Therefore, while the magnanimous attitude of clinical stakeholders facilitated 
improvement of RAIS and strengthened the team, perhaps considering what they can gain 
from being involved is important too, especially since the gains made by stakeholders in this 
instance may help improve surgical care in LMICs even further in the future.  
5.5 Summary 
This addressed Objective 5 of the thesis, using three themes to discuss how the approach 
used to design RAIS benefitted the participants involved. These themes, developed through 
thematic analysis of semi-structured interviews with clinical stakeholder involved in the 
project, were: 
 Motivations and Expectations 
 Ways of Working, Collaborating and Communicating 
 Acquiring Skills, Diversifying Careers and Expanding Networks 
The themes also revealed some key factors, such as implementing an ethos of equal 
stakeholder-ship within the team, might have been important in facilitating or impeding 
stakeholder gains. Combined with evidence of how the design approach influenced the 
development of the RAIS technology, detailed in the previous chapter, the results of this 
chapter are useful for discussing the merit of the approaches used to design RAIS, and make 
suggestions for their development in the next chapter, which concludes the thesis.  
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Chapter 6 
Discussion, Recommendations and Conclusions 
In this chapter, the insights gained from selecting, implementing and evaluating the design 
approaches used to develop the RAIS device are discussed. The outcomes of this work form 
a set of recommendations, intended to guide designers and organisations through the 
process of innovating surgical technologies for LRHCs. The thesis concludes with suggestions 
for future work in this area. 
Work contributing to this chapter was published in the International Journal of Surgery 
Global Health: 
Marriott Webb, M., Bridges, P., Aruparayil, N., Mishra, A., Bains, L., Hall, R., Gnanaraj, J., & 
Culmer, P. (2021). Designing devices for global surgery: Evaluation of participatory and 
frugal design methods. IJS Global Health, 4(1), e50 
6.1 Introduction 
This thesis aimed to investigate approaches to innovating global surgical technologies, which 
is a fundamental strategical aspect of addressing inequalities in access to surgical care 22. In 
this concluding chapter the insights gained developing RAIS and evaluating the design 
approaches pursued are discussed. Six themes for best practice were identified by 
scrutinising all learning outcomes from the design process and performing an iterative 
categorisation process, with feedback from design, engineering and clinical stakeholders 
involved in the project. They findings complement that of wider literature appraising design 
of technologies for LRHCs. The findings can be used by researchers and innovators to 
consider ways of developing design approaches further, to better support innovation of 
frugal surgical technologies and create more disruptive impact on increasing global access 
to quality surgical care. 
6.2 Participatory Design and Stakeholder Engagement: Early, Often, 
Sustained 
As discussed in Chapter 3, the PD approach planned focused on an ethos of embedding 
stakeholders local to the design context within the team, to enhance their Representation 
and Interaction within the project. The aim was to ‘design with’, rather than ‘design for’ this 
group. Chapters 3, 4 and 5 highlighted how this subtle distinction influenced the design 
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methods selected, the technology designed and the experience of and gains for clinical 
stakeholders involved.  
Key challenges and opportunities in implementing this approach were identified. Engaging 
the ‘right’ stakeholders, or an appropriate cross-section of them, is critical to both fully 
define the design context and maximise positive outcomes from PD. Chapter 5 indicated that 
clinical stakeholders based at universities in LMICs, rather than working in LRHCs, could 
benefit more from being involved. In our experience  these ‘proxy users’ were able to 
provide more regular input and are well placed to translate their gains from PD into further 
positive impacts 100. However, Chapter 4 showed their input should supplement, not 
substitute, input from end-users living and working in LRHCs, since proxy users cannot 
always provide the same in-depth knowledge of these contexts. It also highlighted that it is 
desirable to have multiple representatives from each discipline (e.g. surgeons, nurses, 
researchers) to increase creativity, ideas and contextual knowledge, and decrease the risk 
of over-reliance on individual opinion which may not be representative.  
Stakeholder input must also be strategically planned. The initial design phases may require 
more in terms of numbers of local stakeholders and frequency of their input, to build a base 
of contextual knowledge and inform early project decisions. Involving local stakeholders in 
these decisions helps focus the project where it can create impact and builds trust between 
collaborators, which Chapter 5 showed may be necessary to overcome barriers such as 
professional and cultural differences. Convening the design team with many local 
stakeholders within the target context is therefore an ideal means to both start the design 
process and begin building team dynamics which promote multi-directional flows of 
information and equal representation and stakeholder-ship. This should be sustained 
throughout the design process. All stakeholders can, and should, contribute to innovation 
and idea generation 109. Their iterative input in multidisciplinary design sessions can also help 
inform decisions, resolve uncertainties and optimise design functionality. In our experience, 
they provided invaluable insights throughout the design to manufacture phase and their 
contributions as advocates and champions for the gasless surgical technique are central to 
the implementation strategy for RAIS. Their input also facilitated in-country device clinical 
evaluation. Hence, clinical stakeholders can become champions for new technologies and 
be fundamental to propelling the device throughout its dissemination into clinical use and 
adoption 22.  
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Finally, building strong partnerships with stakeholders local to LMICs throughout the project 
can support development of local and international networks with the capacity to innovate 
and evaluate further innovative, frugal surgical technologies within LMICs. Therefore 
considering and prioritising stakeholder gains from being involved could increase the impact 
of the PD approach on increasing access to and quality of surgical care globally. 
6.3 Communication 
This project also underlined the importance of good communication in PD. In this case-study 
the need was amplified by working across different disciplines and continents. This is a 
potential source of conflict, especially when expectations of the project and motivations for 
being involved differ. 
The design team discovered effective strategies for communicating with end-users, such as 
use of semi-structured interviews, making use of follow up questions to clarify concepts and 
to learn about nuances and obscurities of performing surgery in remote contexts. Interacting 
with physical prototypes and live sketching greatly enhanced data collection and 
understanding between all team members during such interviews and group discussions. 
These hands-on methods necessitated in-person meetings, often in a real or simulated 
clinical setting, which clinical stakeholders all agreed was essential for them to thoroughly 
assess designs. However in this design context meeting in person can be time- and resource- 
hungry, so the unique opportunities it provides should be taken advantage of by conducting 
interactive activities that are challenging to perform virtually (such as live surgical 
demonstrations). Such interactions may also be crucial in initiating strong collaborative 
relationships, which can then be maintained using remote communication methods such as 
video conferencing on a regular basis. 
When used to supplement in-person activities, remote communication tools such as email, 
video conferencing and informal instant messaging tools were essential in facilitating 
sustained collaboration and an active team dynamic over large physical distances. In 
particular, video conferencing enables stakeholders to view and control CAD models as well 
as sketch their own ideas. While in our experience this is not a substitute for testing devices 
in a clinical environment, it did help convey complex concepts and gave stakeholders more 
agency in the design process, since they were able to participate effectively in design 
sessions more regularly.  
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The team’s overall approach to interdisciplinary collaboration, which prioritised aspects of 
communication such as listening to and recognising each other’s contributions, and involving 
everyone in planning, updates and decision-making, was important in mitigating potential 
frustrations of clinical stakeholders. They valued this approach and several participants 
began to implement aspects of it within their own roles and encouraged others to use it. 
6.4 Design Tools 
The Design for Safe Surgery Roadmap 31 provides a general framework for design, within 
which it is useful to select specific methods and tools to address each phase of the process, 
as appropriate to the project.  
While some progress has been made on developing novel methods for LMIC-centred design, 
their focus has been on earlier phases of the design process. For example, methods to aid 
definition of healthcare needs in ‘Phase 0’ are well-developed, and need selection can be 
based on existing research or evidence gathered using techniques such as Outcome Driven 
Innovation or Activity Theory 38,101,159. Similarly, detailed methods are available to coordinate 
contextual mapping in ‘Phase 1’ of the design process 31,89,101. However, to advise on later 
design challenges, such as developing design requirements, studies commonly present 
generalised design requirements for medical devices in LMICs, rather than developing 
device-specific guidance 3,31,37,38,44. Most critically, there is a paucity of information on how 
to ‘act’ within the iterative design process described in Phase 3. PD and FI are particularly 
relevant in these stages, however few studies report the challenges of adopting the 
approaches in low-resource settings, for instance the practicalities of obtaining feedback 
from LMIC stakeholders or methods for implementing the principles of frugal engineering 
83,101,102. Finally, whilst it is agreed that surgical technologies developed for LMICs should be 
of comparable quality to those developed for HICs, the roadmap does not suggest use of 
methods to implement quality control or manage design risks 31. 
Our experience found that employing techniques more commonly associated with design in 
HICs can provide valuable structure to guide work in these later phases. For example, the P-
diagram used to summarise the surgical system within which the RAIS device must perform 
was useful throughout later phases of the design process, for developing and assessing 
concepts. The waterfall model used to structure stakeholder input enabled timely feedback 
on design iterations and this formative approach was appreciated by designers and clinical 
stakeholders alike. In each verification loop, the input from the HIC and LMIC users and 
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stakeholders revealed additional nuances of the surgical procedure and context, highlighted 
flaws in the design concepts developed and helped form ideas to eliminate them before the 
validation phase. As reflected earlier, conducting in-person workshops at key points was 
invaluable for optimising the design, and was considered elementary by stakeholders for 
design validation. 
Risk evaluation methods such as FMEA help designers to manage and mitigate adverse 
events in many established design process models 30. In the case study, these evaluation and 
feedback sessions structured using the waterfall model highlighted many risks previously 
unknown to the design team, which were recorded as error states in the P-diagram. In future 
stages of design, such as optimisation, well-recorded discussions during verification and 
validation sessions could be used to form the basis for FMEA and promote early design focus 
on safety and quality. 
6.5 Frugal Innovation in a Complex Environment  
By definition, FI involves a substantial cost reduction, typically through streamlining of 
functionality to achieve an optimised and appropriate performance level 76. In this context 
it should be noted that when reducing costs, consideration of contextual influences such as 
the cost incurred by performing maintenance, procuring spare parts, equipment down-time, 
prolonged hospital stays for patients and training staff is essential. 
The lack of dedicated methods to help the team innovate frugally led to the team developing 
their own strategy, of first setting out absolute minimal functional requirements to achieve, 
designing a solution, and then iteratively improving its value for stakeholders by carefully 
considering their feedback on prototypes. The team found the ‘three defining criteria’ of FI 
76 helped them select concepts, and felt there is certainly scope to formalise this into a 
concept-selection tool for FI, similar to Quality Function Deployment or a Pugh Matrix 160. 
 
The team learnt that FI requires in-depth knowledge of the context, and in particular how it 
affects the value of different device functions for end-users. Information to make design 
decisions can be sparse and the surgical context designed for can vary considerably in LMICs. 
Without specific information about these varying factors it is impossible to optimise design 
performance and value for users. Therefore, the knowledge of local stakeholders is also 
essential to reveal opportunities for FI. Our experience also revealed that they had valuable 
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frugal ideas, which their involvement in the project helped them to recognise the quality of. 
They began to utilise these to innovate their own frugal surgical devices. 
6.6 Responsible Innovation 
While cost reduction is a component of FI, the team found that in this context it cannot be 
the primary focus of the project. Chapter 5 revealed the importance of a shared objective in 
designing a device which improves global access to surgery, especially in terms of 
overcoming barriers to collaboration between professionals from different fields. 
Addressing the needs of patients and end-users must be paramount and the innovation 
process must not negatively impact the quality of the care provided. While some may 
consider this a luxury of research, FIs do not need to compromise on quality to be profitable 
79. Both corporations and universities with funded research initiatives have a part to play in 
global surgical innovation 51. Of course, funded projects are well-positioned to make frugal 
surgical technologies more attractive for future commercial translation by assuming a 
portion of the risks in early stage technology development 117. With this in mind, perhaps 
they may also give consideration to ensuring that stakeholders local to LMICs gain from 
being involved in design. Developing local innovation capacities in LMICs and linking up 
manufacturers, universities, innovators, end-users and policy-makers may ultimately be the 
most efficient way to address inequities in access to surgery across the world 88. 
6.7 The Value of Using a Roadmap 
Chapters 3 and 4 reported how the “Design for Safe Surgery Roadmap” 31 was adapted and 
implemented to design the RAIS device. A key strength of the roadmap was its specific 
recommendations for designing in this context. A prime example is the encouragement to 
co-create with local stakeholders in Phase 3. Chapter 4 revealed that the structured input of 
local stakeholders throughout our iterative design process had been instrumental in 
identifying and resolving major design flaws, ultimately producing an appropriate design for 
a low-resource context. This enabled the team to undertake a full design process and 
achieve a system ready for clinical evaluation and future surgical use. While the potential 
pitfalls were many, the participation and engagement of the multidisciplinary team were at 
the heart of this success. 
While the roadmap did not address the challenges of selecting appropriate methods with 
which to complete each stage of the design process, perhaps the high-level nature of the 
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roadmap was appropriate, considering how varied contexts which global surgical devices 
target are, and how flexible the approach must be to succeed in each 31. However, a 
fundamental impetus for using detailed medical device development models that do 
recommend specific methods (e.g. DFSS 118) is to manage risk and ensure the safety of the 
devices produced 64,161, which is not directly addressed by the roadmap. For example, there 
is no mention of aspects such as quality management systems, which are feasible to 
implement, even for small and mid-sized enterprises and universities, especially if 
stakeholder resources are pooled 119,161. A selection of carefully developed and evaluated 
design tools could help designers manage aspects such as risk or failure modes and aid them 
in producing frugal, participatory designs. 
Finally, while the roadmap 31 provides structure for the initial phases of design, models such 
as the DFSS 118 extend beyond this point of development to consider aspects including design 
for manufacture, regulatory approval, training, maintenance, packaging and disposal. 
Furthermore, there is growing recognition that designers (specifically in the medical device 
industry) should move toward circular life-cycle models, which require detailed 
consideration of resource consumption, re-use and disposal within the design process 162. 
These considerations are important in design for LMICs and for HICs, and may ultimately 
help generate even more appropriate solutions for LRHCs in LMICs. Equally, this may differ 
according to the context, so further guidance for global surgical device designers in later 
design phases should be investigated. Some of this work is underway 39. 
6.8 Recommendations  
Therefore, from this work, the authors propose 11 recommendations for innovators to 
enhance the roadmap 31 and integrate FI and PD in the context of innovating surgical devices 
for LRHCs: 
Participatory Design and Stakeholder Engagement: Early, Often, Sustained 
1. Prioritize input from a variety of stakeholders based in LMICs in the initial design 
phases.  
2. Collaborate with local stakeholders throughout the design process, including later 
phases such as design to manufacture, as equal stakeholders to innovate disruptive 
frugal designs and create more impact on global access to surgery by supporting 
development of innovation networks and capacities within LMICs. 
3. Work with local manufacturers where possible, especially those with experience of 
LRHCs. 
Communication 
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4. Use interactive, in-person methods in early design stages to learn about the context 
and form collaborative relationships with end-users. 
5. Validation should include practical activities with stakeholders based in LRHCs, in 
contexts which emulate the surgical LRHC.  
Design Tools 
6. Semi-structured feedback methods are invaluable for capturing and analysing the 
contextual knowledge of stakeholders and their feedback in later verification and 
validation activities. 
7. Adopt system-based techniques (e.g. P-diagrams) to capture unfamiliar and complex 
contexts and requirements. 
8. Adopt conventional design process models to structure and control risk within the 
technical development process, ensuring stakeholders based in LMICs verify designs. 
Frugal Innovation in a Complex Environment 
9. Generate well-researched requirements to inform frugal idea generation, and re-
evaluate these regularly as the project progresses and understanding of the context 
improves. Avoid over-constraining the design space with excessive or redundant 
requirements. 
Responsible Innovation 
10. In this context improving access to quality surgical care must be a priority over cost 
reduction. 
The Value of Using a Roadmap 
11. The Design for Safe Surgery Roadmap provides a valuable high-level tool for 
structuring initial design phases. 
6.9 Conclusions 
This work produced desirable outcomes. The approach undertaken resulted in development 
of new surgical technology which is ready to undergo clinical trials and regulatory approval, 
and has drawn attention from further stakeholders in LMICs and HICs alike who are 
motivated and well-positioned to disseminate it and the gasless surgical technique further. 
The device and multidisciplinary approach to designing it has captured attention 163 and such 
outputs have drawn further attention to the need for development of technologies for 
global surgery, which is becoming ever more pressing due to the increasing health burden 
created by non-communicable diseases 3. 
Of course, there are limitations to this research. While the future of the RAIS device seems 
promising, there are hurdles to overcome before it and the gasless laparoscopic technique 
are implemented at scale. Reflections on its progression in the long term may provide even 
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further food for thought in relation to the recommendations presented in this thesis. There 
is certainly more to learn about how these approaches affect the device and stakeholders 
involved in the long-term. 
A strength of this research was the exploratory study into Impacts on participating 
stakeholders, discussed in Chapter 6. The semi-structured interviews elicited new findings, 
previously wholly undetected by the research team, which can be used to reflect upon and 
improve our approach to future projects. Evidence of such impacts is scarce in the literature 
and could also be valuable in providing additional impetus for others to use PD for designing 
surgical technologies for LRHCs. However, it was felt this study could have been improved. 
Pilot interviews with other, non-clinical stakeholders in the design team indicated that they 
also gained as much, if not more than the clinical stakeholders from being involved. Their 
inclusion in the study may have helped perform a more complete assessment of the value 
of opportunities for bi-directional learning created by working within global, 
multidisciplinary networks of innovators.  
This frames another limitation of this work. Designing surgical devices is typically a time-
consuming and complex process involving many stakeholders. Evaluating the entire 
development of a device requires a detailed analysis of a great deal of work complete by a 
large team. This is likely to be a major barrier for others attempting to carry out research 
similar to that described in this thesis, and especially for anyone attempting to compare 
multiple projects, which is needed to provide enough evidence to confirm or deny many 
hypotheses. While the objectives of this work were achieved and it provides a detailed case-
study for others to consider, it is of limited used if it cannot be compared and contrasted 
with others. While an overview of an entire design process provides useful detail, this work 
could have benefitted from a more detailed look into some individual aspects of the design 
process. Further development of these approaches will require input from many 
stakeholders across the global health and design communities.  
6.10 Further Work 
To build on and help others implement the recommendations in section 6.8, further research 
is required. Firstly, there is scope to improve design processes for global surgical devices, 
such as the roadmap employed in this work. Future studies could use risk analysis methods 
such as the ‘Process Failure Mode and Effect Analysis’ tool 164 to understand and reduce risks 
in the process of designing technologies within this particular design context. With further 
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evaluation of the risks and opportunities specific to this design context, design processes 
such as the ‘Design for Safe Surgery Roadmap’ could be optimised for generating high-
quality, disruptive technologies 63. 
Secondly, the team found that FI in this context requires great skill in navigating complex 
and generally poorly-understood healthcare environments, and dedication to iteratively 
optimising the value of an innovation in that context. A perfect balance of quality, 
performance, functionality and cost must be struck. To aid innovators in achieving this, 
further work should investigate and adapt design methods to help generate FIs, helping 
designers to make the right design decisions to create disruptive technologies. For example, 
Quality Function Deployment and Pugh matrices could be used to prioritise functionalities 
and select the right concepts 30,160. 
Finally, there is little existing advice on how to implement a PD approach in this context. 
Future work should aim to provide more evidence of the benefits of using a co-creative 
approach 109 and what methods are effective in generating outcomes which can foster the 
development of local innovation capacity in LMICs 165. To generate this evidence, innovators 
should use PD evaluation frameworks such as the Part-E framework 104, or other established 
PD evaluation tools 98,103, to plan to target objectives in more than just the ‘Material Things’ 
attribute, implement appropriate attributes within each dimension to help achieve those 
objectives, and perform systematic evaluations of the PD outcomes. Using these innovative 
frameworks to holistically evaluate PD throughout the design process, innovators can 
demonstrate the benefits of this approach over others 92,98. This will help to increase 
knowledge of the opportunities and challenges and how to maximise outcomes for the 
benefit of increasing global access to surgery. Ultimately, well-thought out and implemented 
PD projects could be used to pull together all the components of the machinery needed to 
create a production line of frugal surgical innovations, such as the RAIS device, in LMICs, and 
hence improve the quality of and access to surgical care globally. 
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Current STAAN abdominal wall-
lifting device 










Instruction Sheet, NASA TLX and 
Questionnaire for Validation Study 
The Gas Insufflation-Less Laparoscopic Surgery (GILLS) technique enables surgeons in 
rural areas of India to perform minimally invasive surgery. It can be performed without 
general anesthetic as well as the carbon dioxide gas and expensive surgical instruments 
required for minimally invasive surgery using gas insufflation, which often rural hospitals 
cannot access. The current abdominal wall-lifting device (right) has shown the GILLS 
procedure to be safe and effective and is used by rural surgeons in Northeast India.  
The NIHR Global Health Research Group - Surgical Technologies (GHRG-ST), 
based at the University of Leeds, has collaborated with partners in India and 
the UK to develop a new device. Our aim is to improve the device so that is 
better-suited to a rural facility (e.g transportable, sterilisable in a flash 
autoclave, easy to repair) and is easier for the surgeon to use. The GHRG-ST 
is also investigating the best ways in which High-Income Countries and Low 
and Middle-Income Countries can work together to design medical devices 
that work for low-resource environments. 
Our new device and its method of use will be presented to you in a video. We would like 
to gather information on how easy it is to set up and use for a surgical procedure. We 
will do this by filming you setting up and using the device on a cadaveric abdominal wall, 
and asking you some questions. This is not a test and you may ask for help at any time. 
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If you wish to take part in the study, you must sign a consent form with an Investigator first. The 
Investigator will ask for a few details from you, and give you a randomized number to protect your data. 
Please write your number on the next sheet of paper in the box provided. 
 
Video Demonstration 
1. Head over to the ‘RAIS’ station. 
2. Please watch the video introduction showing how to assemble and use the device carefully 
Device Assembly 
1. First watch the demonstrator assemble the device. Then assemble it yourself, remembering that: 
 
a) You are the operating surgeon. 
b) The piece that clamps to the surgical table is non-sterile, but imagine the rest of the device has been 
sterilized in a flash autoclave. 
c) You do not need to assemble the ring piece and the clamp piece yet (which attach the device to the 
cadaver and the surgical table) 
 
2. Carry the assembled device over to the cadaver and attach it to the table. 
3. Complete the appropriate NASA Task Load Index overleaf 
Cadaveric abdominal wall lift 
1. Check that an investigator is with you to help and guide you. You may ask the investigator to help you perform 
tasks as you would a surgical assistant or nurse. 
2. Position the device a suitable height above the incision at the Umbilicus of the cadaver. 
3. Insert the ring piece into the incision. 
4. Attach the ring piece to the rest of the device and tighten in position. 
5. Perform the lift of the abdominal wall. 
6. Insert the scope to show you the operative field of view that you are achieving inside the patient on the screen.  
7. Remove the scope, reduce the lift slightly and then move the ring inside the patient to adjust the view of the 
operative field. Increase the lift slightly again and insert the scope to look around. 
8. Lower the lift and remove the ring from the patient. 
9. Complete the appropriate NASA Task Load Index overleaf 
Rural Facility Questionnaire  
Finally, answer the questions on the last page of the booklet about your experience in rural facilities in India and 
abroad. A member of the research team will assist with answering your questions and may ask supplementary 
questions to gain further detail during the process. 
Any questions, just ask! 
 
Instructions 




































Trial Participant Number:                                                         
 
DEVICE ASSEMBLY  
 












CADAVERIC LIFT PROCEDURE 
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3. A rural or low-resource hospital could set up and use this device with the normal number 

























































































Please mark your level of agreement using a ‘circle’ with the following statements 
using your experience and knowledge of a rural/low-resource hospital setting. 




































10. Which system is easier to assemble? 
STAAN 
Device 
  Undecided   
RAIS 
Device 
1 2 3 4 5 6 7 
11. Which device is easier to perform the abdominal wall lift with? 
STAAN 
Device 
  Undecided   
RAIS 
Device 
1 2 3 4 5 6 7 
12. Which device is easier to clean and sterilise? 
STAAN 
Device 
  Undecided   
RAIS 
Device 
1 2 3 4 5 6 7 
13. Which system would you find easier to transport and move around? 
STAAN 
Device 
  Undecided   
RAIS 
Device 
1 2 3 4 5 6 7 
14. Which device would you prefer to use in rural surgery? 
STAAN 
Device 
  Undecided   
RAIS 
Device 
1 2 3 4 5 6 7 
Please use the scale from 1-7 to mark which of the two different abdominal wall-lift devices for GILLS 
performs better in each of the following areas using your experience and knowledge. 




Please tell us about any other barriers you think may prevent this device being used in a 
rural hospital. 
 
 Please use the space below to provide any additional comments, ideas or relevant 
information you would like to tell us. 
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Designing Devices for Global Surgery: 
Evaluation of Stakeholder Gains from the RAIS 
Design Process 
Appendix B 
Participant Information Sheet for 
Participant Gains Study 
 
You are being invited to take part in a research study. Before you decide 
it is important for you to understand why the research is being done 
and what it will involve. Please take time to read the following 
information carefully and discuss it with others if you wish. Ask us if 
there is anything that is not clear or if you would like more information. 
Take time to decide whether or not you wish to take part. 
Study Introduction 
Project RAIS is summarized on Page 4. Through the design of the RAIS 
device, different stakeholders, such as yourself, have been involved in 
designing the device. A timeline of stakeholder involvement in the 
design process can be found in the supplementary document: 
recruitment poster. 
 The top half of each page of the Design Timeline shows who 
was involved, when they were involved, and what activities they 
were involved in.  
 The bottom half of each page of the Design Timeline shows how 
the design changed after the stakeholders were involved. 
This study focuses on the design process and stakeholders involved in 










































We are beginning to evaluate the outcomes of the design project. As well as assessing the RAIS device itself, we would 
like hear about the experience of stakeholders involved in the design process, and in particular anything stakeholders 
may have gained from being involved in designing the RAIS device. This will help us understand how involving 
multidisciplinary stakeholders in designing devices for global surgery affects the stakeholders themselves, and their 
thoughts and feelings about being involved. 
Why have I been chosen? 
You are being asked to participate in this study because you were involved in the design of the RAIS device, in one or 
more of the stages in the Design Timeline (p. 5-7).  
We are interested in anything you might have to say about your feelings about being involved in the design process, 
whether you personally gained anything from participating and why / why not. 
Do I have to take part? 
It is up to you to decide whether or not to take part. If you do decide to take part you will be given this information 
sheet to keep (and be asked to sign a consent form). You can still withdraw from the study at any time before the 
interview without it affecting any benefits that you are entitled to in any way. You do not have to give a reason. 
What will happen if I take part? 
If you would like to participate in this study, you will be asked to complete one short interview. This will be conducted 
via Zoom or Microsoft Teams. To complete the interview, you must have: 
 A device with a microphone (e.g. laptop, tablet, smartphone) 
 Internet connection 
The interviews will take place in March 2021, but the time and date can be arranged according to your schedule.  
Interview Process 
1. If you decide to participate, first you will be asked to sign a consent form (see page 5). Please read this before 
the interview, and if you have any questions please contact the investigator (see contact details below). 
2. The investigator will contact you to arrange a suitable day and time for the interview.  
3. Before the interview, you will be sent a secure Zoom or Microsoft Teams meeting link.  
4. When the meeting starts, the interviewer will check audio quality and ask your consent to record the session. 
5. The interviewer will ask you a number of questions about your experience of the RAIS design process, and any 
effect it has had on you. You can expect the interview to last about 20-30 minutes, but there is no time limit. 
6. When you are ready, the interviewer will conclude the interview. 
7. An anonymous transcript of the interview will be reviewed by the principle investigator and one other 
investigator to discover themes about stakeholder experiences participating in this project. 
8. Some of your words may be directly quoted in published works, namely the principal investigators thesis. You 
can still withdraw your responses from the data collected at any time up until the thesis is submitted (30 th 
June). 
If you have any questions about participating or would like any further information, please contact one of the 
investigators using the following details:  
Primary contact email: M.MarriottWebb@leeds.ac.uk 
Secondary contact email: P.R.Culmer@leeds.ac.uk  
 


































What are the possible benefits of taking part? 
There are no immediate benefits to people participating in the project. It is hoped that this study will be used to refine 
and improve future design processes for designing and implementing surgical devices suitable for low-resource 
settings, and hence accelerate the development and uptake of innovative surgical devices in low-resource settings.   
What are the possible disadvantages and risks of taking part? 
There are no reasonably foreseeable disadvantages to taking part. You will be asked a number of questions about your 
personal experience relating to participating in the design of the RAIS device. Your responses will not affect your 
current involvement in the RAIS project or any other project associated with the GHRG-ST. You may withdraw from the 
study at any time up until you have participated in an interview, and following that you may withdraw your data from 
the study up until the 30th June if you wish to. 
Use and dissemination of research data 
The research data will be analyzed at the University of Leeds following the study. The results may be published in peer-
reviewed journals and international conferences, and will form a chapter of the principal investigator’s thesis focused 
on the design of surgical devices for low-resource settings using participatory methods. We will take steps wherever 
possible to anonymize the research data so that you will not be identified in any reports or publications. Any personal 
data, such as contact information, that we collect about you during the course of the research will be kept strictly 
confidential and will be stored separately from the research data.   
What will happen to my personal information? 
All personal data will be regarded as confidential and will be handled accordingly. Participants will receive a 2 digit 
identification number in order of their enrolment, and this number will be linked to any personal details collected on a 
password-protected computer at the University of Leeds. This data will only be accessed by approved research staff 
working on the study. All hard copies of study documents and written consent forms will be kept in a locked cabinet in 
a locked office. 
Will I be recorded, and how will the recorded media be used? 
Research data collected as audio or video files for future evaluation will also be stored on a secure, encrypted 
computer at the University of Leeds, and will only be correlated to the participant identification number. The recorded 
audio files from the interviews will be transcribed by the investigator for use in thematic analysis. Your anonymized 
responses may be quoted for research purposes in future publications. No other use will be made of them without 
your written permission, and no one outside the project will be allowed access to the original recordings. 
 
 
Thank you for reading!  
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School of Mechanical Engineering  
   
Name of participant  
Participant’s signature  
Date  




Consent to take part in: Designing Devices for Global Surgery: Evaluation of 
Stakeholder Gains from the RAIS Design Process 
Add your initials next 
to the statement if 
you agree 
I confirm that I have read and understand the information sheet dated 
22.02.21 explaining the above research project and I have had the 
opportunity to ask questions about the project. 
 
I understand that my participation is voluntary and that I am free to 
withdraw at any time without giving any reason and without there being any 
negative consequences. In addition, should I not wish to answer any 
particular question or questions, I am free to decline.  
Please contact Millie Marriott Webb if you would like to withdraw your data 
from the study at any time before the 30th June. 
Email: M.MarriottWebb@leeds.ac.uk 
Phone: +44 (113) 34 32141 
If you choose to withdraw from the study, your responses and personal 
information will be permanently deleted and omitted from any current 
publications. It will not be included in any future publications or research. 
 
I understand that members of the research team may have access to my 
anonymised responses. I understand that my name will not be linked with 
the research materials, and I will not be identified or identifiable in the 
report or reports that result from the research.   
 
I understand that the data collected from me may be stored and used in 
relevant future research in an anonymised form. 
 
I agree to take part in the above research project and will inform the lead 
researcher should my contact details change. 
 
  

























Participant should have already returned signed consent form, but ask if they have any further 
questions. Do you give your consent for me to record this interview? 
Explain reasons for conducting the study to set the discussion focus. Explain interview format. 
For example: 
 
1) This is a very early-stage, exploratory study, in which I want to have an open discussion 
about whether you think there have been any advantages or disadvantages for yourself 
from being involved in designing the RAIS device and talk about the reasons for that.  
2) I’d like to stress that your responses will be anonymised and I will not discuss them with 
anyone, so please say your true thoughts. 
3) I’ve prepared seven topics and some questions to help stimulate our discussion. 
4) You also don’t need to answer any questions that you don’t want to – just tell me to 
move on. You can take your time to understand the questions and form your answers.  
5) Some of what we will talk about happened some time ago, so I have made a timeline to 
help stimulate your memories about your involvement in the project, which I can share 
on the screen if helpful for you.  
6) Feel free to ask me any questions as we go along too, especially if anything is unclear. 




Designing Devices for Global Surgery: 
Evaluation of Stakeholder Gains from the RAIS 
Design Process 
Appendix C 
Interview Topic Guide for 
Participant Gains Study 
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Could you briefly describe to me what your job typically involves you doing? 
 
Have you ever been involved in designing something as a part of a group before 
this project? In particular, designing something that affects you – like a new 
healthcare technology, or a new space for your community, or even a new 
system of working e.g. an operating theatre process.  
 







Why did you first become involved in designing the RAIS device? 
 
Do you remember how you felt about being involved in designing the RAIS 
device then?  
 
Was there anything in particular that made you want to be involved in 
designing the RAIS device?  
 
Is there anything that you think made you a good person to be involved in 
designing the RAIS device, perhaps over someone else? 
 
Was there anything that made you not want to be a part of designing the RAIS 






the project  
What do you feel you contributed to the project? 
 
How important do you think your contributions were? 
 
Do you think you could have contributed more? How? Why didn’t you?  
 





Have you acquired new skills or knowledge as a result of your involvement in 
designing the RAIS device? What are they? 
 
What was the most important thing you’ve learnt or discovered? What else did 
you learn? 
 
Have you applied any of the skills or knowledge you have gained so far? 
 










Has participating in the project changed the way you view healthcare 
technologies at all? 
 
Has that had any impact how you work at all, or how you view your role? 
 
Has that made any change for your organisation / practice? 
 
What about for others around you? 
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in the project 
At this stage, is there anything else you thing you have gained from beings 
involved in designing the RAIS device? 
 
Could you have gained more? 
 






in the project 
What is your overall assessment of your experience participating in this 
project?  
 
What is the most important outcome of the project for you? How will that 
affect you?  
 
What was the least important outcome of the project to you? 
 
If the device doesn’t reach a stage where it can be distributed and sold to low-
resource hospitals, will the project have had any impact? 
 
Could this have been different? How? 
 
Is there anything I haven’t asked you that you’d like to say? 
 
 
